<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Venom Anim Toxins Incl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Venom Anim Toxins Incl Trop Dis</journal-id><journal-id journal-id-type="pmc-domain-id">2145</journal-id><journal-id journal-id-type="pmc-domain">jvat</journal-id><journal-id journal-id-type="publisher-id">jvatitd</journal-id><journal-title-group><journal-title>The Journal of Venomous Animals and Toxins Including Tropical Diseases</journal-title></journal-title-group><issn pub-type="epub">1678-9199</issn><publisher><publisher-name>Centro de Estudos de Venenos e Animais Pe&#231;onhentos - CEVAP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431687</article-id><article-id pub-id-type="pmcid-ver">PMC12431687.1</article-id><article-id pub-id-type="pmcaid">12431687</article-id><article-id pub-id-type="pmcaiid">12431687</article-id><article-id pub-id-type="doi">10.1590/1678-9199-JVATITD-2025-0007</article-id><article-id pub-id-type="other">00314</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Proteasome-driven modulation of immune and oxidative pathways during
scorpion envenomation pathogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8156-4013</contrib-id><name name-style="western"><surname>Megdad-Lamraoui</surname><given-names initials="A">Amal</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role>study design</role><role>data acquisition</role><role>analysis</role><role>interpretation</role><role>drafting of the manuscript</role><role>reviewed and approved the final version of the manuscript</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8238-2062</contrib-id><name name-style="western"><surname>Adi-Bessalem</surname><given-names initials="S">Sonia</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role>study conception</role><role>data interpretation</role><role>manuscript revision</role><role>drafting</role><role>reviewed and approved the final version of the manuscript</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7748-9412</contrib-id><name name-style="western"><surname>Daachi</surname><given-names initials="F">Fares</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role>data analysis</role><role>interpretation</role><role>manuscript preparation</role><role>reviewed and approved the final version of the manuscript</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4641-261X</contrib-id><name name-style="western"><surname>Laraba-Djebari</surname><given-names initials="F">Fatima</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c1" ref-type="corresp">*</xref><role>study conception</role><role>data interpretation</role><role>manuscript revision</role><role>drafting</role><role>reviewed and approved the final version of the manuscript</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Laboratory of Cellular and Molecular Biology-Tamayouz, Department of
Cellular and Molecular Biology, Faculty of Biological Sciences, University of
Science and Technology Houari Boumediene (USTHB), Algiers, Algeria.</aff><aff id="aff2">
<label>2</label>Algerian Academy of Sciences and Technology, Algiers, Algeria.</aff><author-notes><corresp id="c1"><label>*</label><bold>Correspondence:</bold><email>flaraba@hotmail.com</email></corresp><fn fn-type="edited-by" id="fn1"><p><bold>Edited by:</bold> Rui Seabra Ferreira Jr.</p></fn><fn fn-type="COI-statement" id="fn4"><p><bold>Competing interests:</bold> The authors declare no conflicts of interest related to the publication of
this manuscript. All financial and personal relationships that could be
perceived as potential conflicts have been fully disclosed.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>31</volume><issue-id pub-id-type="pmc-issue-id">480098</issue-id><elocation-id>e20250007</elocation-id><history><date date-type="received"><day>10</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>&#169; The Author(s). 2025 Open Access This article is distributed under
the terms of the Creative Commons Attribution 4.0 International License
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits
unrestricted use, distribution, and reproduction in any medium, provided you
give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The
Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to
the data made available in this article, unless otherwise
stated.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1678-9199-jvatitd-31-e20250007.pdf"/><abstract><title>Abstract</title><sec><title>Background:</title><p> Scorpion venom contains a variety of toxin molecules that are the drivers of
inflammation and oxidative stress, leading to significant tissue damage.
While several mechanisms underlying these responses have been studied, the
involvement of the proteasome complex - a key regulator of inflammation -
remains poorly understood. This study explored the role of the proteasome in
modulating inflammatory and oxidative responses to envenomation by
<italic toggle="yes">Androctonus australis hector</italic> venom.</p></sec><sec><title>Methods:</title><p> Mice were pretreated intraperitoneally with bortezomib, a proteasome
inhibitor, at low (0.05 mg/kg), medium (0.25 mg/kg), or high (0.5 mg/kg)
doses, 30 minutes prior to sublethal venom administration (0.5 mg/kg,
subcutaneous). Twenty-four hours after venom administration, animals were
euthanized, blood and organs were collected to evaluate vascular
permeability (via Evans blue dye extravasation), the extent of inflammatory
cell infiltration (myeloperoxidase and eosinophil peroxidase enzymatic
activities), and oxidative/nitrosative stress markers (nitric oxide,
hydrogen peroxide<sub>,</sub> malondialdehyde, catalase activity, and
glutathione). Histopathological examinations were performed to identify
structural alterations, such as edema, hemorrhage, and cellular
infiltration. Biochemical parameters reflecting organ function, including
serum levels of CPK, LDH, ALT, ALP, urea, and creatinine, were also measured
to assess the degree of systemic damage.</p></sec><sec><title>Results:</title><p> Our findings revealed a dose-dependent immune-modulatory role of the
proteasome system. A medium dose of bortezomib reduced inflammatory and
oxidative stress markers, such as vascular permeability, eosinophil
peroxidase, neutrophil peroxidase, nitric oxide, and malondialdehyde in
renal tissue, suggesting a reduction in local inflammation and oxidative
damage. In contrast, a higher dose showed pronounced preventive effects in
cardiopulmonary and hepatic tissues, significantly reducing inflammatory
mediators and oxidative markers, restoring antioxidant enzyme activity
(catalase) and glutathione, as well as, improving tissue structure and organ
function.</p></sec><sec><title>Conclusion:</title><p> These findings underscore the proteasome involvement in inflammatory
regulation, likely through modulation of vascular permeability, immune cell
activation, and oxidative stress, making it a key target in scorpion
envenomation.</p></sec></abstract><kwd-group><title>Keywords:</title><kwd>Proteasome</kwd><kwd>Scorpion venom</kwd><kwd>Cardiopulmonary tissue</kwd><kwd>Hepatorenal tissue</kwd><kwd>Immune-inflammatory response</kwd><kwd>Oxidative stress</kwd></kwd-group><counts><fig-count count="7"/><table-count count="1"/><equation-count count="0"/><ref-count count="102"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Background</title><p>Despite several scientific efforts and many therapeutic advances within the last
decades, scorpion stings are still a real threat that remains among the causes of
death especially in children and elderly persons in tropical and subtropical regions
of the world [<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>]. Scorpion envenomation generates various signs ranging from local
effects to systemic manifestations including neurotoxicity, nephrotoxicity,
cytotoxicity, allergic reactions, cardiopulmonary and hepatorenal system dysfunction
[<xref rid="B4" ref-type="bibr">4</xref>-<xref rid="B9" ref-type="bibr">9</xref>]. Scorpion venom contains short and long chain neurotoxic peptides that
modulate the function of ion channels in neuronal terminals and are usually
responsible for the main symptoms of envenoming [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. Besides these neurotoxic
actions, venom components can also induce harmful inflammatory effects and excessive
production of inflammatory mediators by interacting with innate immunity receptors
(TLRs) and involving different inflammatory pathways [<xref rid="B12" ref-type="bibr">12</xref>-<xref rid="B17" ref-type="bibr">17</xref>].</p><p>Previous studies have demonstrated the involvement of several systems in the
occurrence of inflammatory pathophysiological disturbances during scorpion
envenomation - such as the adrenergic, cholinergic, histaminergic, kinin-kallikrein,
renin-angiotensin-aldosterone as well as the complement system - inducing the
release of different mediators including histamine, prostaglandins, leukotrienes and
cytokines [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B18" ref-type="bibr">18</xref>-<xref rid="B24" ref-type="bibr">24</xref>].
Oxidative stress damage caused by excessive reactive oxygen species (ROS) is also
one of the common insults encountered by cells during scorpion envenomation altering
tissue integrity [<xref rid="B25" ref-type="bibr">25</xref>-<xref rid="B29" ref-type="bibr">29</xref>]. It has been shown in various types of cells that modified
proteins by oxidation are selectively hydrolyzed by proteolytic systems [<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>].
The proteasome is the main proteolytic system which is not only involved in abnormal
protein degradation, it also plays a key role in several other fundamental cellular
processes including the regulation of protein homeostasis, major histocompatibility
(MHC) class I antigen processing, cell cycle proliferation, signaling and modulation
of the immune and inflammatory responses [<xref rid="B32" ref-type="bibr">32</xref>-<xref rid="B34" ref-type="bibr">34</xref>]. </p><p>The proteasome system is also known to be involved in regulation of the nuclear
factor-&#954;B (NF-&#954;B) activity, which controls the transcription of a wide range of
genes responsible for inflammation, such as cytokines, adhesion molecules (ICAM-1,
VCAM-1), inducible nitric oxide synthase (iNOS), cyclo-oxygenase 2 (COX-2) and
stress-response proteins [<xref rid="B35" ref-type="bibr">35</xref>-<xref rid="B37" ref-type="bibr">37</xref>]. </p><p>The involvement of the proteasome system in the development of inflammation response
and oxidative stress during scorpion envenomation pathogenesis has not been
investigated. The overall objective of this study was to clarify the immune
modulatory role of the proteasome system in peripheral tissues during scorpion
envenomation.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Venom</title><p>Lyophilized venom of <italic toggle="yes">Androctonus australis hector</italic> (Aah) was
obtained from the Biochemistry of Biomolecules: Mode of Action, Immunotherapy
and Immunodiagnosis team, Laboratory of Cellular and Molecular Biology, Faculty
of Biological Sciences, University of Sciences and Technology Houari Boumediene
(USTHB). A previous study reported that the median lethal dose (LD&#8325;&#8320;) of this
venom is approximately 0.85 mg/kg when administered via the intraperitoneal
(i.p.) route [<xref rid="B38" ref-type="bibr">38</xref>]. In contrast, our prior
work using subcutaneous injection - a route that closely simulates natural
envenomation - demonstrated that a dose of 0.5 mg/kg induces mild envenomation
without resulting in mortality [<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B39" ref-type="bibr">39</xref>].</p></sec><sec><title>Chemicals and drugs</title><p>Bortezomib (Velcade<sup>&#174;</sup>, PS-341) provided by Janssen-Cilag (France), is
used as a proteasome inhibitor. The chemicals and reagents were mainly from
Sigma (St. Louis, MO, USA) and Merck (Mannheim, Germany). </p></sec><sec><title>Animals and experimental design procedure</title><p>The experiments were performed in Algeria using Naval Medical Research Institute
(NMRI) Swiss albino male mice weighing 20-22 g (7-8 weeks old) that did not
undergo previous procedures. They were obtained from the animal breeding center
of the Faculty of Biological Sciences, FBS-USTHB (Algiers, Algeria). They were
housed under a 12-hour light/dark cycle and fed standard pellet chow and tap
water <italic toggle="yes">ad libitum</italic>. All animal experiments were performed
according to the Guide for the Care and Use of Laboratory Animals. All animal
procedures were conducted in compliance with the ethical standards set forth by
the European Parliament and Council Directive on the protection of animals used
for scientific purposes (Directive 2010/63/EU). This study was approved by the
Deontology and Ethic Committee of the Research Thematic Agency in Health
Sciences (ATRSS) formerly National Agency of Research Development in Health
(ANDRS).</p><p>In order to study the immune-modulatory role of proteasome in peripheral tissues
during scorpion envenomation, the animals were randomly divided into five groups
of 12 mice each. They were treated as follows: the first group serving as
control received an injection of 100 &#956;L/mouse of physiological saline water
(NaCl) at 0.9% by subcutaneous route (s.c). The second group represents
envenomed mice with a sublethal dose at 0.5 mg/kg (s.c.), while the third, the
fourth, the fifth and the sixth groups consist of mice receiving three doses of
bortezomib (0.05, 0.25, 0.5 mg/kg) tested intraperitoneally. About 30 minutes
later, mice were envenomed with a sublethal dose of Aah venom (0.5 mg/kg, s.c.).
Control and envenomed mice were euthanized 24 hours after the injection of
physiological saline or venom. In addition to blood, the heart, lungs, liver,
kidneys (from control or treated animals with venom at 0.5 mg/kg) were collected
24 hours after NaCl or venom injection, weighed, and then used for further
investigations. </p></sec><sec><title>Enumeration of the different peripheral blood leukocyte populations</title><p>Blood samples were taken in tubes with EDTA 24 hours after the injection of Aah
venom. The cell count was carried out by a hemocytometer ERMA INC (full
automatic blood cell counter model PCE-210N) analyzer. Blood cells were
identified according to the position of the nucleus, its area and its density.
The results are expressed as 10<sup>3</sup> cells/&#956;L of blood.</p></sec><sec><title>Serum protein electrophoresis </title><p>Serum protein electrophoresis was carried out using an automatic device of the
&#8220;Capillary SEBIA&#8221; type. Serum proteins (albumin and &#945;1, &#945;2, &#946;, &#947; globulins) are
amphoteric molecules, their separation takes place according to their electrical
charges. The serum samples from the different groups were placed in a basic
medium (cellulose acetate) where the serum proteins acquired an overall negative
charge allowing them to migrate from the cathode to the anode under the
influence of an electric field. The migration was stopped as soon as the
separation was sufficient; a fixation was then carried out with the acid blue
dye. Five zones corresponding to the different serum proteins having decreasing
negative charges were obtained. The results were expressed in g/L. </p></sec><sec><title>Vascular permeability and inflammatory cell infiltration</title><p>
<italic toggle="yes">Vascular permeability</italic>
</p><p>To measure changes in vascular permeability, Evans blue dye was administered
intravenously (20 mg/kg) immediately before the injection of NaCl or venom
[<xref rid="B40" ref-type="bibr">40</xref>]. The organs - heart, lungs,
liver and kidneys - were collected after mouse euthanasia. They were then placed
in formamide for the extraction of Evans blue, then incubated at 37&#176;C for 72
hours. Absorbance was read at 620 nm and the results were expressed as the
concentration of Evans blue per &#181;g of tissue.</p><p>
<italic toggle="yes">Myeloperoxidase activity</italic>
</p><p>The accumulation and activation of neutrophils were analyzed by measuring
myeloperoxidase (MPO) in tissue homogenates according to the method described by
Coelho et al. [<xref rid="B41" ref-type="bibr">41</xref>]. The oxidation of the
chromogenic substrate, O-dianisidine, by MPO was measured by spectrophotometry
at 460 nm. A volume of 1 mL of 50 Mm phosphate buffer (pH 6.6) containing
O-dianisidine dihydrochloride (0.167 mg/mL) and hydrogen peroxide, was added to
1 mL of biological sample. The oxidation of the chromogenic substrate
O-dianisidine by MPO was measured spectrophotometrically at 460 nm Changes in
absorbance were recorded over 2minutes. MPO activity was expressed as mM/min/100
mg of tissue or mM/min/ mL of serum, using an extinction coefficient (&#949;) of 11.3
mM&#8315;&#185;&#183;cm&#8315;&#185;.</p><p>
<italic toggle="yes">Eosinophil peroxidase activity</italic>
</p><p>The evaluation of the eosinophil peroxidase (EPO) activity, a marker for
eosinophil accumulation, was carried out according to the method described by
Van Oosterhout et al. [<xref rid="B42" ref-type="bibr">42</xref>]. Supernatants
(50 &#181;L) were placed in the wells of a microplate with 100 &#956;L of buffer solution
[<xref rid="B50" ref-type="bibr">50</xref> mM Tris-HCl, pH <xref rid="B8" ref-type="bibr">8</xref>, containing <xref rid="B20" ref-type="bibr">20</xref> mg of o-phenylenediamine (OPD) and <xref rid="B10" ref-type="bibr">10</xref> &#181;L of H&#8322;O&#8322;]. Enzyme activity was assessed by measuring
absorbance at 490 nm after 1 hour of incubation at 37&#176;C. Results are expressed
as absorbance per 100 mg of tissue.</p></sec><sec><title>Oxidative stress markers</title><p>Oxidative stress was evaluated by measuring the levels of pro-oxidant
(malondialdehyde and nitrites) and antioxidants biomarkers (catalase CAT and
glutathione GSH) in tissue homogenates.</p><p>
<italic toggle="yes">Nitric oxide</italic>
</p><p>The level of nitric oxide was determined by measuring nitrites [<xref rid="B43" ref-type="bibr">43</xref>]. Nitrite levels were evaluated in the
various samples using the Griess method. The samples were deproteinized with TCA
(10%) and then incubated volume for volume with Griess reagent (1% sulfanilamide
and 0.1% naphthylethylenediamine dihydrochloride in 2.5% phosphoric acid) for 20
min at room temperature. Nitrite levels were measured spectrophotometrically at
540 nm. A standard curve was prepared using a stock solution of KNO<sub>2</sub>.
Nitrite concentrations are expressed in &#181;M/g of tissue.</p><p>
<italic toggle="yes">Hydrogen peroxide</italic>
</p><p>The estimation of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) levels is based
on the oxidation of phenol red by H<sub>2</sub>O<sub>2</sub> via peroxidase
[<xref rid="B44" ref-type="bibr">44</xref>]. The samples were distributed in
a microplate at a rate of 100 &#181;L/well supplemented with 100 &#181;L of a reactive
solution of phenol red [0.01 g glucose, 0.0001 g of horseradish peroxidase (HRP)
0.0001 g phenol red in 10 mL PBS]. The plate was then incubated for one hour at
37&#176;C, protected from light. The reaction was stopped by adding 10 &#181;L of NaOH
(1N). Absorbance readings were taken at 620 nm microplate reader. The
concentration of hydrogen peroxide was determined after extrapolation on a
standard curve made for different concentrations of H<sub>2</sub>O<sub>2</sub>
ranging from 0.005 mM to 0.500 mM. Results were expressed as mM/100 mg
tissue.</p><p>
<italic toggle="yes">Malondialdehyde</italic>
</p><p>Malondialdehyde, an indicator of lipid peroxidation, is one of the end products
of the breakdown of polyunsaturated fatty acids, it is released under the effect
of free radicals during stress. The malondialdehyde level was evaluated
according to the method of Moreno et al. [<xref rid="B45" ref-type="bibr">45</xref>]. The samples from the different groups are incubated (v/v) with
TCA (35 %) for 1 hour at 4&#176;C for protein precipitation. After centrifugation of
the mixture for 10 minutes at 4000 <italic toggle="yes">g</italic>, 200 &#956;L of the supernatant
were mixed with 100 &#956;L of SDS (8.1%), 750 &#956;L of acetic acid (20%), 750 &#956;L of
thiobarbituric acid (0.8%) and 200 &#956;L of distilled water. The mixture was then
incubated at 100&#176;C for 1 hour, followed by cooling in ice. The optical density
was measured at 532 nm and the amount of malondialdehyde formed was calculated
using a molar extinction coefficient of 1.56 x 10<sup>5</sup> M<sup>-1</sup>
cm<sup>-1</sup>. Results were expressed in nM/ 100 mg of tissue.</p><p>
<italic toggle="yes">Catalase activity</italic>
</p><p>Catalase is a ubiquitous antioxidant enzyme. It is responsible for the conversion
of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) into water (H<sub>2</sub>O)
and oxygen (O<sub>2</sub>). The enzymatic reaction is triggered by the addition
of 50 &#956;L of each sample and of the substrate (0.2% H<sub>2</sub>O<sub>2</sub>)
in phosphate buffer (50 mM at pH 7). The kinetics of H<sub>2</sub>O<sub>2</sub>
degradation were measured spectrophotometrically at 240 nm for 3 min. One unit
of catalase is equal to (2.3/T) (Log A1/A2), where T is the time interval in
minutes, A1 the absorbance in the first minute and A2 the absorbance in the
second minute [<xref rid="B46" ref-type="bibr">46</xref>]. Catalase activity was
expressed in U/100 mg of tissue.</p><p>
<italic toggle="yes">Glutathione</italic>
</p><p>Glutathione plays an important role in the detoxification and reduction of both
organic and inorganic peroxides, in the presence of glutathione peroxidase
(GPx). Its quantification is based on the measurement of the optical absorbance
of 2-nitro-5-mercapturic acid, which results from the reduction of
5,5'-dithio-bis-2-nitrobenzoic acid by the (-SH) groups of GSH [<xref rid="B47" ref-type="bibr">47</xref>]. To carry out this assay, a volume of
50 &#181;L of sample was mixed with 100 &#181;L of DTNB (5,5'-dithio-bis (2-nitrobenzoic
acid) and 100 &#181;L of phosphate buffer (0.1 M and pH 7.4) The absorbance reading
was taken at 450 nm after a 30 minute incubation at 37&#176;C. The results were
expressed in &#181;M / 100 mg of tissue using a molar extinction coefficient of 13.3
M<sup>-1</sup>.cm<sup>-1</sup>
</p></sec><sec><title>Histopathological analysis</title><p>The effects of proteasome inhibitor on Aah venom induced cardiac, pulmonary, and
hepatorenal tissues alteration were examined by histological analysis. </p><p>Organs (liver, kidneys, heart, lungs) were collected from the animals, fixed in
formalin (10%), and embedded in paraffin. The resulting tissue blocks were
sectioned using a microtome to obtain 5 &#181;m thick sections. These sections were
stained with hematoxylin and eosin to visualize tissue damage under a light
microscope.</p></sec><sec><title>Evaluation of organ functions</title><p>Organ function was assessed by estimating the enzyme activities of creatine
phosphokinase (CPK), lactate dehydrogenase (LDH), alanine aminotransferase
(ALT), alkaline phosphatase (ALP), as well as by measuring urea and creatinine
levels in serum, according to the manufacturer's (Spinreact, Spain)
instructions. Enzyme activities were expressed in international units (IU/L).
Serum creatinine and urea levels were expressed in g/L.</p></sec><sec><title>Statistical analysis </title><p>Results are expressed as means &#177; SEM. Statistical comparisons were carried out
using One-Way ANOVA (Graph Pad Prism 5 Software, San Diego, CA, USA) to identify
differences between the envenomed and control groups or between the pretreated
and the envenomed groups. A value of <italic toggle="yes">p</italic> &lt; 0.05 was considered
statistically significant.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Effects of proteasome inhibitor on blood cells and serum alpha, beta and
gamma globulins concentration</title><p>Blood leukocyte levels were assessed in the presence of low (0.05 mg/kg), medium
(0.25 mg/kg), or high (0.5 mg/kg) doses of proteasome inhibitor before
experimental envenomation. The results showed that scorpion venom induced
hyperleukocytosis 24 hours after envenomation of the mice, compared to the
control group, as evidenced by a significant increase in the levels of
lymphocytes (<italic toggle="yes">p</italic> &lt; 0.001), monocytes (<italic toggle="yes">p</italic> &lt;
0.01), and granulocytes (<italic toggle="yes">p</italic> &lt; 0.05) (<xref rid="f1" ref-type="fig">Figure 1A</xref>). This migration is likely induced by various
immune stimuli, such as the pro-inflammatory cytokines released after scorpion
envenomation [<xref rid="B48" ref-type="bibr">48</xref>-<xref rid="B51" ref-type="bibr">51</xref>]. </p><p>Serum proteins from the acute phase of inflammation are key markers of the
inflammatory response. Electrophoresis analysis revealed an increase in the
alpha and gamma globulin fractions in the sera of envenomed mice exposed to a
sublethal dose of Aah venom (<xref rid="f1" ref-type="fig">Figure 1B</xref>).
Gamma globulins are synthesized following the activation of B lymphocytes. The
increase in this fraction indicates the synthesis of various types of
immunoglobulins in serum (IgA, IgG, IgM, IgD, IgE) and C-reactive protein
(CRP).</p><p>Higher doses of proteasome inhibitor (0.25 and 0.5 mg/kg) induced a significant
decrease in the level of lymphocytes (<italic toggle="yes">p</italic> &lt; 0.05 and
<italic toggle="yes">p</italic> &lt; 0.01), monocytes (<italic toggle="yes">p</italic> &lt; 0.01 and
<italic toggle="yes">p</italic> &lt; 0.001) and granulocytes (<italic toggle="yes">p</italic> &lt;
0.05 and <italic toggle="yes">p</italic> &lt; 0.01), comparatively to that of envenomed mice.
It seems that this pretreatment was able to significantly prevent
hyperleukocytosis induced by Aah venom in the blood (<xref rid="f1" ref-type="fig">Figure 1A</xref>).</p><p>
<fig position="float" id="f1" orientation="portrait"><label>Figure 1. </label><caption><title>(A) Effects of proteasome inhibition on leukocyte levels and (B)
serum protein contents 24 hours after envenomation. Values are
expressed as mean &#177; SEM (n = 3/group). Student's t-test, *p &lt;
0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt;0.0001: groups of
envenomed (0.5 mg/kg) mice compared to the control group (NaCl).
<sup>#</sup>p &lt; 0.05; <sup>##</sup>p &lt; 0.01;
<sup>###</sup>p &lt; 0.001; <sup>####</sup>p &lt;0.0001:
pretreated groups compared to the group of envenomed (0.5 mg/kg)
mice. ns: non-significant results.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf1.jpg"/></fig>
</p><p>With regard to the effects on the serum protein electrophoresis, pretreatment of
mice with a low dose of bortezomib (0.05 mg/kg) induced a significant decrease
in all globulin fractions (&#945;1, &#945;2, &#946;, and &#947;) compared to the values recorded in
the envenomed group of mice. Bortezomib at 0.25 and 0.5 mg/kg significantly
reduced the &#945;1, &#945;2, &#946;- and &#947;-globulin fractions, compared to the envenomed group
of mice. However, a more pronounced decrease in all globulin fractions was
observed at the higher concentration of bortezomib (0.5 mg/kg), compared to the
effects recorded at the lower doses (<xref rid="f1" ref-type="fig">Figure
1B</xref>).</p></sec><sec><title>Effect of pretreatment with proteasome inhibitor on serum albumin level and
organ water content</title><p>Compared with the control group, the levels of albumin were significantly
decreased in envenomed animals (<italic toggle="yes">p</italic> &lt; 0.0001) (<xref rid="f2" ref-type="fig">Figure 2A</xref>). This hypoalbuminemia is
accompanied by high water content in the heart, lungs, liver and kidneys of
envenomed animals compared with normal controls. Albumin is a negative acute
phase protein. Leakage of serum albumin levels due to increased vascular
permeability can contribute to edema formation in tissues [<xref rid="B52" ref-type="bibr">52</xref>]. Bortezomib at 0.5 mg/kg significantly prevented the
decrease in albumin rates compared with the venom group (<italic toggle="yes">p</italic> &lt;
0.05). However, no significant effect was observed at lower concentrations (0.05
and 0.25 mg/kg) (<xref rid="f2" ref-type="fig">Figure 2A</xref>). Similarly,
with regard to tissue water content, bortezomib at the highest concentration
tended to prevent edema formation in the cardiac, pulmonary, kidneys and hepatic
tissues (<xref rid="f2" ref-type="fig">Figure 2B</xref>). These results suggest
that Aah venom induces edema formation, by activating in part the proteasome
complex.</p><p>
<fig position="float" id="f2" orientation="portrait"><label>Figure 2.</label><caption><title>
<bold>(A)</bold> Effects of proteasome inhibition on serum albumin
levels and <bold>(B)</bold> peripheral tissue water content 24 hours
after envenomation. Values are expressed as mean &#177; SEM (n =
3/group). Student's t-test, *p &lt; 0.05; **p &lt; 0.01; ***p &lt;
0.001; ****p &lt; 0.0001: groups of envenomed (0.5 mg/kg) mice
compared to the control group (NaCl). <sup>#</sup>p &lt; 0.05;
<sup>##</sup>p &lt; 0.01; <sup>###</sup>p &lt; 0.001;
<sup>####</sup>p &lt; 0.0001: pretreated groups compared to the
group of envenomed (0.5 mg/kg) mice. ns: non-significant
results.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf2.jpg"/></fig>
</p></sec><sec><title>Evaluation of vascular permeability and inflammatory cell infiltration in
peripheral tissues</title><p>Vascular permeability in various peripheral tissues was assessed by quantifying
Evans blue extravasation [<xref rid="B40" ref-type="bibr">40</xref>]. The
increase in vascular permeability in damaged tissue reflects the movement of a
significant volume of plasma from blood capillaries into the tissues. This
plasma flow transports a substantial number of inflammatory mediators [<xref rid="B53" ref-type="bibr">53</xref>] leading in particular to edema
formation in tissues. Results showed that 24 hours after injection, Aah venom
induces a significant increase in vascular permeability of heart
(<italic toggle="yes">p</italic> &lt; 0.0001), lungs (<italic toggle="yes">p</italic> &lt; 0.0001),
liver (<italic toggle="yes">p</italic> &lt; 0.001) and renal (<italic toggle="yes">p</italic> &lt; 0.001)
tissues (<xref rid="f3" ref-type="fig">Figure 3A</xref>). These results are
similar to those carried out previously by our team [<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. </p><p>
<fig position="float" id="f3" orientation="portrait"><label>Figure 3.</label><caption><title>Effects of low (0.05 mg/kg), medium (0.25 mg.kg) or high dose
(0.5 mg/kg) of bortezomib on <bold>(A)</bold> vascular permeability
changes and inflammatory cell infiltration including
<bold>(B)</bold> neutrophils and <bold>(C)</bold> eosinophils in
peripheral tissues of envenomed mice by Aah venom. Values are
expressed as mean &#177; SEM (n = 3/group). Student's
<italic toggle="yes">t</italic>-test, *p &lt; 0.05; **p &lt; 0.01; ***p &lt;
0.001; ****p &lt; 0.0001: groups of envenomed mice compared to the
control group (NaCl). <sup>#</sup>p &lt; 0.05; <sup>##</sup>p &lt;
0.01; <sup>###</sup>p &lt; 0.001; <sup>####</sup>p &lt; 0.0001:
pretreated groups compared to the group of envenomed (0.5 mg/kg)
mice. ns: non-significant results.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf3.jpg"/></fig>
</p><p>The increase in vascular permeability facilitates the migration of leukocytes
from the vascular system to the injured area. Peroxidase activities were
measured as markers of neutrophil and eosinophil activation. Myeloperoxidase and
eosinophil peroxidase activities were significantly elevated in the tissue
homogenates of animals injected with Aah venom compared to the control group
(<xref rid="f3" ref-type="fig">Figure 3B</xref> and <xref rid="f3" ref-type="fig">3C</xref>). </p><p>According to the results, pretreatment with low (0.05 mg/kg), medium (0.25
mg/kg), and high (0.5 mg/kg) doses of proteasome inhibitor significantly reduced
Aah venom-induced Evans blue extravasation in cardiac and pulmonary tissues in a
concentration-dependent manner. However, in renal tissue, this effect was not
dose-dependent, as the highest dose of bortezomib (0.5 mg/kg) failed to prevent
the increase in vascular permeability to the same extent as the lower dose
(<xref rid="f3" ref-type="fig">Figure 3A</xref>).</p><p>The activities of myeloperoxidase and eosinophil peroxidase significantly
decreased in the group of animals treated with a higher dose of bortezomib
(<italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">p</italic> &lt; 0.0001,
<italic toggle="yes">p</italic> &lt; 0.01) compared to the values observed in the heart,
lungs, and liver tissues of animals envenomed with Aah venom alone. In the renal
tissue it appears that, the medium dose (0.25 mg/kg) of bortezomib is more
effective (<italic toggle="yes">p</italic> &lt; 0.05) than the low and high doses in reducing
the infiltration of neutrophils and eosinophils (<xref rid="f3" ref-type="fig">Figure 3B</xref> and <xref rid="f3" ref-type="fig">3C</xref>).</p></sec><sec><title>Evaluation of oxidative stress status in peripheral tissues in the presence
or absence of increasing doses of proteasome inhibitor</title><p>The inflammatory response induced by Aah venom was associated with a significant
increase in nitrites, hydrogen peroxide, and malondialdehyde levels, along with
a decrease in glutathione content and catalase activity compared to the controls
(<xref rid="f4" ref-type="fig">Figures 4A</xref>, <xref rid="f4" ref-type="fig">4B</xref> and <xref rid="f4" ref-type="fig">4C</xref>). Previous
studies have suggested that the infiltration of inflammatory cells (including
neutrophils and eosinophils) may lead to increased release of reactive oxygen
and nitrogen species accompanied by an alteration of the antioxidant defense
system [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B54" ref-type="bibr">54</xref>]. </p><p>
<fig position="float" id="f4" orientation="portrait"><label>Figure 4.</label><caption><title>Effects of low (0.05 mg/kg), medium (0.25 mg.kg) or high dose
(0.5 mg /kg) of bortezomib on <bold>(A)</bold> hydrogen peroxide,
<bold>(B)</bold> nitrites and <bold>(C)</bold> malondialdehyde
levels in peripheral tissues of envenomed mice by Aah venom. Values
are expressed as mean &#177; SEM (n = 3/group). Student's
<italic toggle="yes">t</italic>-test, *<italic toggle="yes">p</italic> &lt; 0.05;
**<italic toggle="yes">p</italic> &lt; 0.01; ***<italic toggle="yes">p</italic> &lt;
0.001; ****<italic toggle="yes">p</italic> &lt; 0.0001: groups of envenomed (0.5
mg/kg) mice compared to the control group (NaCl). <sup>#</sup>
<italic toggle="yes">p</italic> &lt; 0.05; <sup>##</sup>
<italic toggle="yes">p</italic> &lt; 0.01; <sup>###</sup>
<italic toggle="yes">p</italic> &lt; 0.001; <sup>####</sup>
<italic toggle="yes">p</italic> &lt; 0.0001: pretreated groups compared to the
group of envenomed (0.5 mg/kg) mice. ns: non-significant
results.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf4.jpg"/></fig>
</p><p>Pretreatment with bortezomib reduced the levels of pro-oxidant markers (MDA,
nitrites, H<sub>2</sub>O<sub>2</sub>) and prevented dysfunction of the
antioxidant defense system (CAT and GSH) in the peripheral tissue homogenates of
envenomed mice. The high dose (0.5 mg/kg) appears to be more effective in
reducing nitrite and hydrogen peroxide levels, as well as lipid peroxidation,
compared to the low and medium doses in all studied tissues, except in renal
tissue, when compared to the respective values recorded in envenomed mice
without pretreatment (<xref rid="f4" ref-type="fig">Figures 4A</xref>, <xref rid="f4" ref-type="fig">4B </xref>and <xref rid="f4" ref-type="fig">4C</xref>). In the renal tissue, significant decrease in pro-oxidant
markers were noted in the group receiving a medium-dose (0.25 mg/kg) of
bortezomib in comparison with envenomed mice (<xref rid="f4" ref-type="fig">Figures 4A</xref>, <xref rid="f4" ref-type="fig">4B</xref>and <xref rid="f4" ref-type="fig">4C</xref>). </p><p>The decrease in pro-oxidant markers was associated with an improved antioxidant
status, characterized by the restoration of catalase activity and GSH levels in
peripheral tissues, compared to the animals injected with Aah venom. Significant
results were observed in heart and lung homogenates of mice pretreated with the
high dose of bortezomib. At the hepatic level, this dose did not have an effect
on the restoration of glutathione levels in the liver. In the kidneys, it
appears that the medium and low doses were respectively more effective in
preventing alterations in the non-enzymatic (<italic toggle="yes">p</italic> &gt; 0.05,
<italic toggle="yes">p</italic> &lt; 0.001) and enzymatic (<italic toggle="yes">p</italic> &lt; 0.05)
antioxidant systems (<italic toggle="yes">p</italic> &lt; 0.0001, <italic toggle="yes">p</italic> &lt;
0.05) and enzymatic (<italic toggle="yes">p</italic> &lt; 0.05) (<xref rid="f5" ref-type="fig">Figure 5A</xref> and <xref rid="f5" ref-type="fig">5B</xref>).</p><p>
<fig position="float" id="f5" orientation="portrait"><label>Figure 5.</label><caption><title>Effects of bortezomib (0.05 mg/kg, 0.25 mg.kg and 0.5 mg /kg) on
<bold>(A)</bold> glutathione and <bold>(B)</bold> catalase
activity in peripheral tissues of envenomed mice by Aah venom.
Values are expressed as mean &#177; SEM (n = 3/group). Student's
<italic toggle="yes">t</italic>-test, *<italic toggle="yes">p</italic> &lt; 0.05;
**<italic toggle="yes">p</italic> &lt; 0.01; ***<italic toggle="yes">p</italic> &lt;
0.001; ****<italic toggle="yes">p</italic> &lt; 0.0001: groups of envenomed (0.5
mg/kg) mice compared to the control group (NaCl). <sup>#</sup>
<italic toggle="yes">p</italic> &lt; 0.05; <sup>##</sup>
<italic toggle="yes">p</italic> &lt; 0.01; <sup>###</sup>
<italic toggle="yes">p</italic> &lt; 0.001; <sup>####</sup>
<italic toggle="yes">p</italic> &lt; 0.0001: pretreated groups compared to the
group of envenomed (0.5 mg/kg) mice. ns: non-significant results.
</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf5.jpg"/></fig>
</p></sec><sec><title>Histopathological analysis and the effects of proteasome inhibitor on
biomarker levels of organ function in envenomed animals</title><p>To further evaluate the role of the proteasome in tissue injuries induced by
scorpion venom, histopathological analysis of H&amp;E-stained sections was
performed. Histological sections of heart, liver, lung, and kidney tissues from
the control group showed normal structure without any histological changes
(<xref rid="f6" ref-type="fig">Figures 6A</xref> and <xref rid="f6" ref-type="fig">6F</xref>, and <xref rid="f7" ref-type="fig">Figures 7A</xref> and
<xref rid="f7" ref-type="fig">7F</xref>). However, scorpion venom
administration induced tissue damage, characterized by the loss of normal
histological structure, infiltration of inflammatory cells, thickening of the
alveolar septa, as well as edema and hemorrhage (<xref rid="f6" ref-type="fig">Figures 6B</xref>and <xref rid="f6" ref-type="fig">6G</xref>, and <xref rid="f7" ref-type="fig">Figures 7B</xref> and <xref rid="f7" ref-type="fig">7G</xref>). These histological changes were accompanied by a significant
increase in CPK, ALT, ALP, LDH, urea, and creatinine levels in the sera of
envenomed mice (<xref rid="t1" ref-type="table">Table 1</xref>). The increase in
these markers may be attributed to impaired organ function, as shown in previous
studies [<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>]. </p><p>Following treatment with a high dose of bortezomib, administered
intraperitoneally 30 minutes before envenomation, tissue alterations were
significantly reduced in the heart, liver, and lungs (<xref rid="f6" ref-type="fig">Figures 6E </xref>and <xref rid="f6" ref-type="fig">6J</xref>, and
<xref rid="f7" ref-type="fig">Figure 7E</xref>). This pretreatment
significantly reduced the activities of CPK (69.28%), ALT (23.63%), ALP
(52.37%), and LDH (20.67%) compared to the animals injected with Aah venom
(<xref rid="t1" ref-type="table">Table 1</xref>). The low and medium doses
of bortezomib treatment resulted in a slight reduction in histological injuries
in these organs. However, some histological alterations, such as edema,
inflammatory cell infiltration, and congestion of the central vein, persisted
(<xref rid="f6" ref-type="fig">Figures 6C</xref>, <xref rid="f6" ref-type="fig">6H</xref>, <xref rid="f6" ref-type="fig">6D </xref>and <xref rid="f6" ref-type="fig">6I</xref>, and <xref rid="f7" ref-type="fig">Figures
7C</xref>and <xref rid="f7" ref-type="fig">7D</xref>). </p><p>In the renal tissue, marked reduction of tissue alterations was observed in
average-dose (0.25 mg/kg) of bortezomib in pretreated group of mice <xref rid="f7" ref-type="fig">(Figure 7I</xref>) accompanied with significant
decrease in urea (73.21%) and creatinine (28.42%) levels when compared to
envenomed group of mice (<xref rid="t1" ref-type="table">Table 1</xref>). </p><p>
<fig position="float" id="f6" orientation="portrait"><label>Figure 6.</label><caption><title>Effects of proteasome inhibition on (<bold>A-E</bold>) myocardial
and (<bold>F-J</bold>) hepatic tissue, 24 h after Aah envenomation.
(<bold>A, F</bold>) Control (NaCl). (<bold>B, G</bold>) Animals
injected with Aah venom (s.c). (<bold>C, H</bold>) Animals
pretreated with a low dose bortezomib (0.05 mg/kg, i.p.). (<bold>D,
I</bold>) Animals pretreated with a medium dose bortezomib (0.25
mg/kg, i.p.). (<bold>E, J</bold>) Animals pretreated with a high
dose bortezomib (0.5 mg/kg, i.p.). Hematoxylin-eosin staining,
magnification &#215; 400. Cv: center-lobe vein; CCv: congested
center-lobe vein; Ed: edema; H: hemorrhage; HEd: hemorrhagic edema;
Ic: inflammatory cell infiltrates; N: nucleus.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf6.jpg"/></fig>
</p><p>
<fig position="float" id="f7" orientation="portrait"><label>Figure 7.</label><caption><title>Effects of proteasome inhibition on (<bold>A-E</bold>) pulmonary
and (<bold>F-J</bold>) renal tissue structure, 24 h after Aah
envenomation. (<bold>A, F</bold>) Control (NaCl). (<bold>B,
G</bold>) Animals injected with Aah venom (s.c). (<bold>C, H</bold>)
Animals pretreated with a low dose bortezomib (0.05 mg/kg, i.p.).
(<bold>D, I</bold>) Animals pretreated with a medium dose
bortezomib (0.25 mg/kg, i.p.). (<bold>E, J</bold>) Animals
pretreated with a high dose bortezomib (0.5 mg/kg, i.p.).
Hematoxylin-eosin staining, magnification &#215; 400. A: alveolar; DT:
distal tubule; E: edema; Gl: glomerulus; HEd: hemorrhagic edema; H:
hemorrhage; Ic: inflammatory cell infiltrates; Is: inter-alveolar
septum; Nc: necrosis; PT: proximal tubule; TIs: thick inter-alveolar
septum.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-9199-jvatitd-31-e20250007-gf7.jpg"/></fig>
</p><p>
<table-wrap position="float" id="t1" orientation="portrait"><label>Table 1.</label><caption><title>Effects of proteasome inhibition on serum biomarkers of tissue
damage. Values represented in the table are expressed as mean &#177; SEM
(n = 3/group). Student's <italic toggle="yes">t</italic>-test,
*<italic toggle="yes">p</italic> &lt; 0.05; **<italic toggle="yes">p</italic> &lt; 0.01;
***<italic toggle="yes">p</italic> &lt; 0.001; ****<italic toggle="yes">p</italic> &lt;
0.0001: groups of envenomed (0.5 mg/kg) mice compared to the control
group (NaCl). <sup>#</sup>
<italic toggle="yes">p</italic> &lt; 0.05; <sup>##</sup>
<italic toggle="yes">p</italic> &lt; 0.01; <sup>###</sup>
<italic toggle="yes">p</italic> &lt; 0.001; <sup>####</sup>
<italic toggle="yes">p</italic> &lt; 0.0001: pretreated groups compared to the
group of envenomed (0.5 mg/kg) mice. ns: non-significant
results.</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">Control (NaCl)</th><th align="center" rowspan="1" colspan="1">Venom</th><th align="center" rowspan="1" colspan="1">Bortezomib (0.05 mg/kg) + venom</th><th align="center" rowspan="1" colspan="1">Bortezomib (0.25 mg/kg) + venom</th><th align="center" rowspan="1" colspan="1">Bortezomib (0.5 mg/kg) + venom</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>CPK (IU/L)</bold>
</td><td align="center" rowspan="1" colspan="1">1626.66 &#177; 46.45</td><td align="center" rowspan="1" colspan="1">2530 &#177; 107.33<sup>***</sup>
</td><td align="center" rowspan="1" colspan="1">2070.33 &#177; 306.77<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">2000.33 &#177; 100.10<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">1605.66 &#177; 2.88<sup>###</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>ALT (IU/L)</bold>
</td><td align="center" rowspan="1" colspan="1">35.83 &#177; 4.59</td><td align="center" rowspan="1" colspan="1">170.28 &#177; 18.25<sup>****</sup>
</td><td align="center" rowspan="1" colspan="1">164.16 &#177; 7.63 <sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">132.00 &#177; 12.58 <sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">38.33 &#177; 12.58<sup>####</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>ALP (IU/L)</bold>
</td><td align="center" rowspan="1" colspan="1">84.53 &#177; 9.47</td><td align="center" rowspan="1" colspan="1">193.89 &#177; 17.68<sup>**</sup>
</td><td align="center" rowspan="1" colspan="1">122 &#177; 31.32<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">100 &#177; 21.32<sup>##</sup>
</td><td align="center" rowspan="1" colspan="1">102.33 &#177; 28.29<sup>####</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>LDH (IU/L)</bold>
</td><td align="center" rowspan="1" colspan="1">1698.66 &#177; 34.42</td><td align="center" rowspan="1" colspan="1">1895.00 &#177; 107.58 </td><td align="center" rowspan="1" colspan="1">1836.68&#177;60.27<sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">1721.66 &#177; 235.39<sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">1503.33 &#177; 66.16<sup>#</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Urea (g/L)</bold>
</td><td align="center" rowspan="1" colspan="1">0.16 &#177; 0.04</td><td align="center" rowspan="1" colspan="1">0.42 &#177; 0.03<sup>****</sup>
</td><td align="center" rowspan="1" colspan="1">0.40 &#177; 0.01<sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">0.26 &#177; 0.01<sup>##</sup>
</td><td align="center" rowspan="1" colspan="1">0.37 &#177; 0.06<sup>ns</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Creatinine (g/L)</bold>
</td><td align="center" rowspan="1" colspan="1">3.33 &#177; 0.57</td><td align="center" rowspan="1" colspan="1">11.33 &#177; 2.3<sup>**</sup>
</td><td align="center" rowspan="1" colspan="1">8 &#177; 2.00 <sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">7 &#177; 2.00<sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">11 &#177; 2.64<sup>ns</sup>
</td></tr></tbody></table></table-wrap>
</p></sec></sec><sec sec-type="discussion"><title>Discussion </title><p>Involvement of the proteasome system during various inflammatory diseases was
reported and has been directly linked to the progression of these diseases [<xref rid="B57" ref-type="bibr">57</xref>-<xref rid="B61" ref-type="bibr">61</xref>].
However, no study has yet demonstrated its role in the pathogenesis of scorpion
envenomation. </p><p>In this study, we investigated the role of the proteasome in Aah venom-induced
toxicity and evaluated the potential immune-modulatory role of bortezomib, a
proteasome inhibitor, through its impact on vascular, oxidative and biochemical
markers.</p><p>The present study showed that experimental envenomation with Aah venom triggered
systemic immune system activation, characterized by increased blood cell counts and
acute-phase protein levels, along with hypoalbuminemia. These findings are
consistent with previous studies on scorpion envenomation, which have also reported
systemic inflammatory responses, including leukocytosis, elevated acute-phase
reactants, and reduced albumin levels [<xref rid="B62" ref-type="bibr">62</xref>-<xref rid="B64" ref-type="bibr">64</xref>]. The earliest response to
envenomation is vascular dysfunction, characterized by increased vascular
permeability and tissue edema. This was reflected in our study by elevated tissue
water content and Evans blue dye extravasation in multiple organs. Similar results
were reported in previous studies on scorpion envenomation [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. Hypoalbuminemia
observed in this context may result from increased vascular permeability, which
facilitates the leakage of albumin and other plasma proteins into tissues.
Hypoalbuminemia reduces plasma oncotic pressure, leading to fluid leakage into
tissues, which results in organ water accumulation, tissue swelling, and potential
functional impairment [<xref rid="B65" ref-type="bibr">65</xref>]. The vascular
leakage is often associated with inflammatory cell infiltration, as confirmed in
this study by the elevated activities of myeloperoxidase (MPO) and eosinophil
peroxidase (EPO), enzymatic markers of neutrophil and eosinophil accumulation,
respectively. These immune cells are known to be major sources of reactive oxygen
species, such as hydrogen peroxide (H&#8322;O&#8322;) generated from superoxide anions, as well
as reactive nitrogen species like nitric oxide (NO) [<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>]. The overproduction of
nitric oxide (NO) and reactive oxygen species (ROS) during envenomation leads to a
significant redox imbalance, partly due to reduced antioxidant defense, as shown by
the decreased glutathione level and catalase activity likely inhibited by excess
H&#8322;O&#8322; [<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>]. These reactive species act as cytotoxic agents by inducing lipid
peroxidation, compromising cell membrane integrity [<xref rid="B70" ref-type="bibr">70</xref>]. This was evaluated by elevated malondialdehyde (MDA) levels, both
in our study and in previous experimental and clinical reports [<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B71" ref-type="bibr">71</xref>],
reflecting oxidative tissue damage. Histological analysis further revealed
venom-induced cardiac, pulmonary and hepatorenal alterations, including hemorrhage,
edema, and inflammatory cell infiltration. These results were also obtained by
previous studies on scorpion envenomation [<xref rid="B4" ref-type="bibr">4</xref>,
<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B72" ref-type="bibr">72</xref>-<xref rid="B74" ref-type="bibr">74</xref>]. </p><p>The histological alterations induced by Aah venom were accurately reflected in the
serum by elevated CPK, ALT, ALP and LDH activities, which are commonly associated
with the severity of tissue damage in cases of scorpion envenomation [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B19" ref-type="bibr">19</xref>].
These pathological manifestations are consistent with clinical observations in human
scorpion envenomation<bold>.</bold> They include systemic inflammatory response,
cardiovascular dysfunction, pulmonary edema [<xref rid="B75" ref-type="bibr">75</xref>-<xref rid="B77" ref-type="bibr">77</xref>] and hepatorenal
manifestations [<xref rid="B78" ref-type="bibr">78</xref>-<xref rid="B80" ref-type="bibr">80</xref>]. Several studies have emphasized the relevance of
pro-inflammatory mediators in the pathophysiological manifestations of human
scorpion envenomation [<xref rid="B16" ref-type="bibr">16</xref>]. Moreover, there
is a significant association between these complications and oxidative stress
induced by venom components [<xref rid="B81" ref-type="bibr">81</xref>], as well as
the release of organ dysfunction biomarkers such as LDH, CPK, and ALT, which are
commonly elevated in clinical cases of envenomation and reflect systemic tissue
injury [<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B78" ref-type="bibr">78</xref>].The findings of the present study are in line with these clinical
features, as experimental envenomation in mice led to increased vascular
permeability, inflammatory infiltration, and organ damage. The observed increase in
inflammatory and oxidative markers mirrors the pathophysiological processes seen in
human victims, thereby validating the experimental model used.</p><p>The results of this study demonstrated that pretreatment of mice with a proteasome
inhibitor introduced at low (0.05 mg/kg), medium (0.25 mg/kg) or high (0.5 mg/kg)
doses prior to administration of the venom reduced the levels of inflammatory and
oxidative markers seen in scorpion envenomation in a dose-dependent manner. A more
preventive effect was observed at the cardiac, pulmonary and hepatic levels in the
presence of a high concentration of bortezomib (0.5 mg/kg). In the renal tissue, it
appears that the medium dose (0.25 mg/kg) of the proteasome inhibitor is more
effective in reducing the immune inflammatory response. Several studies have
demonstrated the effectiveness of these doses in reducing inflammation response
during experimental inflammatory pathologies [<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>]. In the present research,
bortezomib appeared to prevent the increase in vascular permeability and the
increase in tissue water content. These observations are supported by previous
studies that link proteasome inhibition to reduced endothelial activation and
permeability in inflammatory settings [<xref rid="B84" ref-type="bibr">84</xref>].
We did not directly assess the molecular markers of vascular leakage or tight
junction integrity in the present study, but the reduction in Evans blue
concentration in organs, tissue edema and MPO and EPO activities in treated animals
indirectly supports a protective role of proteasome inhibition against vascular
barrier dysfunction suggesting a stabilizing effect on endothelial integrity.</p><p>Although not directly assessed in this study, it is plausible that the proteasome
inhibitor influenced cellular signaling networks such as NF-&#954;B, which governs
inflammatory responses. The NF-&#954;B is a key driver of inflammation, its activation
relies on proper proteasome function [<xref rid="B85" ref-type="bibr">85</xref>].
The NF-kB would be activated by the proteasome responsible for the degradation and
cleavage of the I&#954;B-NF-&#954;B complex, the release of the factor NF-&#954;B and its
translocation into the nucleus for the expression of pro-inflammatory mediators
[<xref rid="B86" ref-type="bibr">86</xref>].</p><p>The decrease in the rate of vascular permeability, which precedes the infiltration of
inflammatory cells, may be due to the fact that the inhibition of the proteasome
prior to envenomation can prevent the activation of the NF-kB factor, which could be
activated by Toll-like receptors (TLR-2 and TLR-4) [<xref rid="B73" ref-type="bibr">73</xref>]. TLRs and their signaling pathways are currently being validated as
potential immune-modulatory targets during scorpion envenomation pathogenesis [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>,
<xref rid="B73" ref-type="bibr">73</xref>]. Since these receptors are expressed
in circulating and resident immune cells, including mast cells [<xref rid="B87" ref-type="bibr">87</xref>]. Inhibition of this signaling pathway
prevents the release of preformed inflammatory mediators such as histamine and lipid
derived mediators [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>], and thereby reduced vascular permeability. The decrease in
peroxidase activities (MPO and EPO) in peripheral tissues after Aah envenomation in
the presence of bortezomib could be partly attributed to the reduced vascular
permeability observed in this study, which may have limited leukocyte extravasation.
However, this reduction might also result from additional mechanisms, such as the
apoptotic effects of proteasome inhibition on leukocytic cells, which may contribute
to their immunosuppression [<xref rid="B88" ref-type="bibr">88</xref>-<xref rid="B90" ref-type="bibr">90</xref>]. It could also contribute to the reduction
of the involved inflammatory mediators in the recruitment of polymorphonuclear cells
such as cytokines (IL-2, IL-5, IL-8) [<xref rid="B91" ref-type="bibr">91</xref>] and
adhesion molecules on the endothelium like E selectins, VCAM -1 and ICAM-1 and
P-selectin [<xref rid="B92" ref-type="bibr">92</xref>-<xref rid="B94" ref-type="bibr">94</xref>]. </p><p>The inhibition of proteasome resulted also in the prevention of oxidative balance
alteration during Aah envenomation. This could be explained by the reduction in
infiltrated neutrophil and eosinophil cells which represent important sources of
reactive oxygen intermediates such as H<sub>2</sub>O<sub>2</sub> and NO [<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>].
Previous studies demonstrated also that increased production of ROS leads to the
activation of NF&#312;B. This, in turn, stimulates the synthesis of other
pro-inflammatory mediators such as adhesion molecules, which contribute to
exacerbation of the inflammatory response [<xref rid="B95" ref-type="bibr">95</xref>]. It has been earlier shown that the inhibition of the proteasome system
with the use of selective inhibitors blocks the induction of iNOS by preventing
activation of nuclear factor&#8208;&#954;B [<xref rid="B96" ref-type="bibr">96</xref>-<xref rid="B98" ref-type="bibr">98</xref>]. This is associated with the upregulation
of several endogenous antioxidants such as SOD, GSH&#8208;Px and catalase contributing to
significant improvement of tissue alteration [<xref rid="B99" ref-type="bibr">99</xref>]. This was in accordance with our results and with another previous
report, which demonstrated that proteasome system inhibition may lead to increased
antioxidant enzyme activities [<xref rid="B100" ref-type="bibr">100</xref>]. It
reduces tissue oxidative damage which in turn prevents the release of the enzymatic
cell contents (CPK, LDH, ALP, and ALT), as well as urea and creatinine levels. </p><p>The mechanism of the anti-inflammatory effect observed following inhibition of the
proteasome prior to envenomation of mice might be more complex. Based on the results
obtained in this study and supported by bibliographic data, we suggest that proteins
modified by conjugation with lipid peroxidation products produced during scorpion
envenomation may undergo ubiquitination and subsequent degradation by the proteasome
[<xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B102" ref-type="bibr">102</xref>]. These degraded proteins can then be presented to T cells
<italic toggle="yes">via</italic> a class 1 MHC molecule. The onset of a cytotoxic immune
response can worsen the tissue damage observed after scorpion envenomation.
According to these data, it is possible to suggest that during scorpion
envenomation, tissue damage is mediated by both the Th2 and Th1 immune pathways
involving the proteasome system [<xref rid="B11" ref-type="bibr">11</xref>].</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In conclusion, the results of this study demonstrate, for the first time, the
immunomodulatory role of the proteasome during scorpion envenomation. Administration
of bortezomib effectively suppresses systemic inflammation by reducing vascular
permeability, tissue edema, and peroxidase activities (MPO and EPO), while also
enhancing the expression of antioxidants such as GSH and catalase. These effects
ultimately contribute to the prevention of lipid peroxidation and tissue damage.
Further investigations are warranted to explore the involvement of key inflammatory
pathways, including NF-&#954;B and Nrf2 signaling, as well as to elucidate the precise
mechanisms underlying the proteasome-mediated regulation of inflammation and
oxidative stress.</p><sec><title>Abbreviations</title><p>Aah: <italic toggle="yes">Androctonus australis hector</italic>, ALP: alkaline phosphatase,
ALT: alanine aminotransferase, ARE: antioxidant response element, CAT: catalase,
COX-2: cyclooxygenase 2, CPK: creatine-phosphokinase, CRP: C-reactive protein,
DTNB: 5,5'-dithiobis(2-nitrobenzoic acid), EDTA: ethylenediaminetetraacetic
acid, EPO: eosinophil peroxidase, GPx: glutathione peroxidase, GSH: reduced
glutathione, ICAM-1: intercellular adhesion molecule 1, iNOS: inducible nitric
oxide synthase, LDH: lactate dehydrogenase, MDA: malondialdehyde, MHC: major
histocompatibility complex, MPO: myeloperoxidase, NF-kB: nuclear factor kappa B,
NMRI: Naval Medical Research Institute, NRf2: nuclear erythroid-2 like factor-2,
OPD: o-phenylenediamine, PBS: phosphate-buffered saline, SDS: sodium dodecyl
sulfate, SEM: standard error of the mean, TCA: trichloroacetic acid, TLRs:
toll-like receptors, VCAM-1: vascular cell adhesion molecule 1.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors extend their heartfelt gratitude to all the participants who generously
contributed their time and effort to this study.</p></ack><fn-group><fn fn-type="financial-disclosure" id="fn3"><p><bold>Funding:</bold> This research was carried out without financial support from public agencies,
commercial entities, or non-profit organizations.</p></fn><fn fn-type="other" id="fn6"><p><bold>Ethics approval and consent to participate:</bold> All animal procedures were conducted in compliance with the ethical standards
set forth by the European Parliament and Council Directive on the protection of
animals used for scientific purposes (Directive 2010/63/EU). This study was
approved by the Deontology and Ethic Committee of the Research Thematic Agency
in Health Science (ATRSS) formerly National Agency of Research Development in
Health (ANDRS).</p></fn><fn fn-type="other" id="fn7"><p><bold>Consent for publication:</bold> Not applicable</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abroug</surname><given-names>F</given-names></name><name name-style="western"><surname>Ouanes-Besbes</surname><given-names>L</given-names></name><name name-style="western"><surname>Tilouche</surname><given-names>N</given-names></name><name name-style="western"><surname>Elatrous</surname><given-names>S</given-names></name></person-group><article-title>Scorpion envenomation: state of the art</article-title><source>Intensive Care Med</source><year>2020</year><volume>46</volume><issue>3</issue><fpage>401</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1007/s00134-020-05924-8</pub-id><pub-id pub-id-type="pmid">32125457</pub-id></element-citation></ref><ref id="B2"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boubekeur</surname><given-names>K</given-names></name><name name-style="western"><surname>L&#8217;Hadj</surname><given-names>M</given-names></name><name name-style="western"><surname>Selmane</surname><given-names>S</given-names></name></person-group><article-title>Demographic and epidemiological characteristics of scorpion
envenomation and daily forecasting of scorpion sting counts in Touggourt,
Algeria</article-title><source>Epidemiol health</source><year>2020</year><volume>42</volume><elocation-id>e2020050</elocation-id><pub-id pub-id-type="doi">10.4178/epih.e2020050</pub-id><pub-id pub-id-type="pmid">32660217</pub-id><pub-id pub-id-type="pmcid">PMC7871152</pub-id></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alhelail</surname><given-names>M</given-names></name><name name-style="western"><surname>Albelali</surname><given-names>A</given-names></name><name name-style="western"><surname>Alkanhal</surname><given-names>R</given-names></name><name name-style="western"><surname>Salam</surname><given-names>M</given-names></name></person-group><article-title>Severity of scorpion envenomation in Saudi Arabia: A systematic
review</article-title><source>Toxicol Rep</source><year>2024</year><elocation-id>101749</elocation-id><pub-id pub-id-type="doi">10.1016/j.toxrep.2024.101749</pub-id><pub-id pub-id-type="pmid">39391710</pub-id><pub-id pub-id-type="pmcid">PMC11466650</pub-id></element-citation></ref><ref id="B4"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Effet de l&#8217;immunoth&#233;rapie sur les modifications m&#233;taboliques et
histopathologiques apr&#232;s envenimation scorpionique
exp&#233;rimentale</article-title><source>Bull Soc Pathol Exot</source><year>2003</year><volume>96</volume><issue>2</issue><fpage>110</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">12836528</pub-id></element-citation></ref><ref id="B5"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heidarpour</surname><given-names>M</given-names></name><name name-style="western"><surname>Ennaifer</surname><given-names>E</given-names></name><name name-style="western"><surname>Ahari</surname><given-names>H</given-names></name><name name-style="western"><surname>Srairi-Abid</surname><given-names>N</given-names></name><name name-style="western"><surname>Borchani</surname><given-names>L</given-names></name><name name-style="western"><surname>Khalili</surname><given-names>G</given-names></name><name name-style="western"><surname>Amini</surname><given-names>H</given-names></name><name name-style="western"><surname>Anvar</surname><given-names>AA</given-names></name><name name-style="western"><surname>Boubaker</surname><given-names>S</given-names></name><name name-style="western"><surname>El-Ayeb</surname><given-names>M</given-names></name><name name-style="western"><surname>Shahbazzadeh</surname><given-names>D</given-names></name></person-group><article-title>Histopathological changes induced by Hemiscorpius lepturus
scorpion venom in mice</article-title><source>Toxicon</source><year>2012</year><volume>59</volume><issue>3</issue><fpage>373</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2011.12.011</pub-id><pub-id pub-id-type="pmid">22230352</pub-id></element-citation></ref><ref id="B6"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamraoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Modulation of tissue inflammatory response by histamine receptors
in scorpion envenomation pathogenesis: involvement of H4
receptor</article-title><source>Inflammation</source><year>2014</year><volume>37</volume><fpage>1689</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-9898-x</pub-id><pub-id pub-id-type="pmid">24858599</pub-id></element-citation></ref><ref id="B7"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cha&#239;r-Yousfi</surname><given-names>I</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name></person-group><article-title>Androctonus australis hector venom contributes to the interaction
between neuropeptides and mast cells in pulmonary
hyperresponsiveness</article-title><source>Int Immunopharmacol</source><year>2015</year><volume>25</volume><issue>1</issue><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2015.01.008</pub-id><pub-id pub-id-type="pmid">25601496</pub-id></element-citation></ref><ref id="B8"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamraoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Immunopathologic effects of scorpion venom on hepato-renal
tissues: Involvement of lipid derived inflammatory mediators</article-title><source>Exp Mol Pathol</source><year>2015</year><volume>99</volume><issue>2</issue><fpage>286</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2015.07.013</pub-id><pub-id pub-id-type="pmid">26231296</pub-id></element-citation></ref><ref id="B9"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haddad-Ishak-boushaki</surname><given-names>W</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Age-related changes in inflammatory response after experimental
envenomation: impact on the susceptibility to Androctonus australis hector
venom</article-title><source>Inflammation</source><year>2017</year><volume>40</volume><fpage>1131</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1007/s10753-017-0557-x</pub-id><pub-id pub-id-type="pmid">28405853</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>M</given-names></name></person-group><article-title>The scorpion envenoming syndrome</article-title><source>Toxicon</source><year>1995</year><volume>33</volume><issue>7</issue><fpage>825</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(95)00005-7</pub-id><pub-id pub-id-type="pmid">8588209</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petricevich</surname><given-names>VL</given-names></name></person-group><article-title>Scorpion venom and the inflammatory response</article-title><source>Mediators Inflamm</source><year>2010</year><volume>2010</volume><issue>1</issue><elocation-id>903295</elocation-id><pub-id pub-id-type="doi">10.1155/2010/903295</pub-id><pub-id pub-id-type="pmid">20300540</pub-id><pub-id pub-id-type="pmcid">PMC2838227</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magalh&#227;es</surname><given-names>MM</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>ME</given-names></name><name name-style="western"><surname>Amaral</surname><given-names>CF</given-names></name><name name-style="western"><surname>Rezende</surname><given-names>NA</given-names></name><name name-style="western"><surname>Campolina</surname><given-names>D</given-names></name><name name-style="western"><surname>Bucaretchi</surname><given-names>F</given-names></name><name name-style="western"><surname>Gazzinelli</surname><given-names>RT</given-names></name><name name-style="western"><surname>Cunha-Melo</surname><given-names>JR</given-names></name></person-group><article-title>Serum levels of cytokines in patients envenomed by Tityus
serrulatus scorpion sting</article-title><source>Toxicon</source><year>1999</year><volume>37</volume><issue>8</issue><fpage>1155</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(98)00251-7</pub-id><pub-id pub-id-type="pmid">10400299</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Mendil</surname><given-names>A</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Lung immunoreactivity and airway inflammation: their assessment
after scorpion envenomation</article-title><source>Inflammation</source><year>2012</year><volume>35</volume><issue>2</issue><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1007/s10753-011-9338-0</pub-id><pub-id pub-id-type="pmid">21547500</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ait-Lounis</surname><given-names>A</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>TNF-alpha modulates adipose macrophage polarization to M1
phenotype in response to scorpion venom</article-title><source>Inflamm Res</source><year>2015</year><volume>64</volume><fpage>929</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1007/s00011-015-0876-z</pub-id><pub-id pub-id-type="pmid">26403661</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoccal</surname><given-names>KF</given-names></name><name name-style="western"><surname>Paula-Silva</surname><given-names>FW</given-names></name><name name-style="western"><surname>da Silva Bitencourt</surname><given-names>C</given-names></name><name name-style="western"><surname>Sorgi</surname><given-names>CA</given-names></name><name name-style="western"><surname>Bordon</surname><given-names>KD</given-names></name><name name-style="western"><surname>Arantes</surname><given-names>EC</given-names></name><name name-style="western"><surname>Faccioli</surname><given-names>LH</given-names></name></person-group><article-title>PPAR-&#947; activation by Tityus serrulatus venom regulates lipid body
formation and lipid mediator production</article-title><source>Toxicon</source><year>2015</year><volume>93</volume><fpage>90</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2014.11.226</pub-id><pub-id pub-id-type="pmid">25450800</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reis</surname><given-names>MB</given-names></name><name name-style="western"><surname>Zoccal</surname><given-names>KF</given-names></name><name name-style="western"><surname>Gardinassi</surname><given-names>LG</given-names></name><name name-style="western"><surname>Faccioli</surname><given-names>LH</given-names></name></person-group><article-title>Scorpion envenomation and inflammation: Beyond neurotoxic
effects</article-title><source>Toxicon</source><year>2019</year><volume>167</volume><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2019.06.219</pub-id><pub-id pub-id-type="pmid">31228480</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khemili</surname><given-names>D</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name></person-group><article-title>Involvement of toll-like receptor 4 in neutrophil-mediated
inflammation, oxidative stress and tissue damage induced by scorpion
venom</article-title><source>Inflammation</source><year>2020</year><volume>43</volume><issue>1</issue><fpage>155</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1007/s10753-019-01105-y</pub-id><pub-id pub-id-type="pmid">31654297</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukuhara</surname><given-names>YD</given-names></name><name name-style="western"><surname>Reis</surname><given-names>ML</given-names></name><name name-style="western"><surname>Dellalibera-Joviliano</surname><given-names>R</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>FQ</given-names></name><name name-style="western"><surname>Donadi</surname><given-names>EA</given-names></name></person-group><article-title>Increased plasma levels of IL-1&#946;, IL-6, IL-8, IL-10 and TNF-&#945; in
patients moderately or severely envenomed by Tityus serrulatus scorpion
sting</article-title><source>Toxicon</source><year>2003</year><volume>41</volume><issue>1</issue><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(02)00208-8</pub-id><pub-id pub-id-type="pmid">12467661</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name><name name-style="western"><surname>Ferquel</surname><given-names>E</given-names></name><name name-style="western"><surname>Robbe-Vincent</surname><given-names>A</given-names></name><name name-style="western"><surname>Bon</surname><given-names>C</given-names></name><name name-style="western"><surname>Choumet</surname><given-names>V</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Epidemiological data, clinical admission gradation and biological
quantification by ELISA of scorpion envenomations in Algeria: effect of
immunotherapy</article-title><source>Transactions of the royal society of tropical medicine and
hygiene</source><year>2004</year><volume>98</volume><issue>4</issue><fpage>240</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(03)00062-2</pub-id><pub-id pub-id-type="pmid">15049463</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bekkari</surname><given-names>N</given-names></name><name name-style="western"><surname>Martin-Eauclaire</surname><given-names>MF</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Complement system and immunological mediators: their involvements
in the induced inflammatory process by Androctonus australis hector venom
and its toxic components</article-title><source>Exp Toxicol Pathol</source><year>2015</year><volume>67</volume><issue>7-8</issue><fpage>389</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2015.04.002</pub-id><pub-id pub-id-type="pmid">25921955</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medjadba</surname><given-names>W</given-names></name><name name-style="western"><surname>Martin-Eauclaire</surname><given-names>MF</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Involvement of kallikrein-Kinin system on cardiopulmonary
alterations and inflammatory response induced by purified Aah I toxin from
scorpion venom</article-title><source>Inflammation</source><year>2016</year><volume>39</volume><fpage>290</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1007/s10753-015-0249-3</pub-id><pub-id pub-id-type="pmid">26361946</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakib</surname><given-names>I</given-names></name><name name-style="western"><surname>Martin-Eauclaire</surname><given-names>MF</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Involvement of cholinergic and adrenergic receptors in
pathogenesis and inflammatory response induced by alpha-neurotoxin Bot III
of scorpion venom</article-title><source>Inflammation</source><year>2016</year><volume>39</volume><fpage>1670</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1007/s10753-016-0401-8</pub-id><pub-id pub-id-type="pmid">27395044</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sifi</surname><given-names>A</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Role of angiotensin II and angiotensin type-1 receptor in
scorpion venom-induced cardiac and aortic tissue
inflammation</article-title><source>Exp Mol Pathol</source><year>2017</year><volume>102</volume><issue>1</issue><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2016.11.006</pub-id><pub-id pub-id-type="pmid">27955986</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sifi</surname><given-names>A</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Involvement of the endothelin receptor type A in the
cardiovascular inflammatory response following scorpion
envenomation</article-title><source>Toxins</source><year>2020</year><volume>12</volume><issue>6</issue><fpage>389</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.3390/toxins12060389</pub-id><pub-id pub-id-type="pmid">32545475</pub-id><pub-id pub-id-type="pmcid">PMC7374423</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dousset</surname><given-names>E</given-names></name><name name-style="western"><surname>Carrega</surname><given-names>L</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>JG</given-names></name><name name-style="western"><surname>Clot-Faybesse</surname><given-names>O</given-names></name><name name-style="western"><surname>Jouirou</surname><given-names>B</given-names></name><name name-style="western"><surname>Sauze</surname><given-names>N</given-names></name><name name-style="western"><surname>Devaux</surname><given-names>C</given-names></name><name name-style="western"><surname>Autier</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jammes</surname><given-names>Y</given-names></name><name name-style="western"><surname>Martin-Eauclaire</surname><given-names>MF</given-names></name><name name-style="western"><surname>Guieu</surname><given-names>R</given-names></name></person-group><article-title>Evidence that free radical generation occurs during scorpion
envenomation</article-title><source>Comp Biochem Physiol C</source><year>2005</year><volume>140</volume><issue>2</issue><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2005.02.003</pub-id><pub-id pub-id-type="pmid">15907767</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raouraoua-Boukari</surname><given-names>R</given-names></name><name name-style="western"><surname>Sami-Merah</surname><given-names>S</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name><name name-style="western"><surname>Martin-Eauclaire</surname><given-names>MF</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Immunomodulation of the inflammatory response induced by
Androctonus australis hector neurotoxins: biomarker
interactions</article-title><source>Neuroimmunomodulation</source><year>2012</year><volume>19</volume><issue>2</issue><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1159/000330241</pub-id><pub-id pub-id-type="pmid">22248726</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galvani</surname><given-names>NC</given-names></name><name name-style="western"><surname>Vilela</surname><given-names>TC</given-names></name><name name-style="western"><surname>Domingos</surname><given-names>AC</given-names></name><name name-style="western"><surname>Fagundes</surname><given-names>M&#205;</given-names></name><name name-style="western"><surname>Bosa</surname><given-names>LM</given-names></name><name name-style="western"><surname>Della Vechia</surname><given-names>IC</given-names></name><name name-style="western"><surname>Scussel</surname><given-names>R</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M</given-names></name><name name-style="western"><surname>Steiner</surname><given-names>BT</given-names></name><name name-style="western"><surname>Damiani</surname><given-names>AP</given-names></name><name name-style="western"><surname>Ch&#225;vez-Ol&#243;rtegui</surname><given-names>C</given-names></name></person-group><article-title>Genotoxicity evaluation induced by Tityus serrulatus scorpion
venom in mice</article-title><source>Toxicon</source><year>2017</year><volume>140</volume><fpage>132</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2017.10.024</pub-id><pub-id pub-id-type="pmid">29107080</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khadem</surname><given-names>MD</given-names></name><name name-style="western"><surname>Rasooli</surname><given-names>A</given-names></name><name name-style="western"><surname>Mashhadi</surname><given-names>AG</given-names></name><name name-style="western"><surname>Shahriari</surname><given-names>A</given-names></name><name name-style="western"><surname>Mohammadian</surname><given-names>B</given-names></name><name name-style="western"><surname>Barati</surname><given-names>F</given-names></name></person-group><article-title>Evaluation of oxidant/antioxidant status in serum of sheep
experimentally envenomated with Hemiscorpius lepturus scorpion
venom</article-title><source>Vet Res Forum</source><year>2019</year><volume>10</volume><issue>2</issue><elocation-id>165</elocation-id><pub-id pub-id-type="doi">10.30466/vrf.2018.80273.2066</pub-id><pub-id pub-id-type="pmid">31338151</pub-id><pub-id pub-id-type="pmcid">PMC6626647</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daachi</surname><given-names>F</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Megdad-Lamraoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Immune-toxicity effects of scorpion venom on the hypothalamic
pituitary adrenal axis during rest and activity phases in a rodent
model</article-title><source>Comp Biochem Physiol C</source><year>2020</year><volume>235</volume><elocation-id>108787</elocation-id><pub-id pub-id-type="doi">10.1016/j.cbpc.2020.108787</pub-id><pub-id pub-id-type="pmid">32380264</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H</given-names></name><name name-style="western"><surname>Tan</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name></person-group><article-title>The role of ubiquitin-proteasome pathway and autophagy-lysosome
pathway in cerebral ischemia</article-title><source>Oxid Med Cell Longev</source><year>2020</year><volume>2020</volume><issue>1</issue><elocation-id>5457049</elocation-id><pub-id pub-id-type="doi">10.1155/2020/5457049</pub-id><pub-id pub-id-type="pmid">32089771</pub-id><pub-id pub-id-type="pmcid">PMC7016479</pub-id></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korolchuk</surname><given-names>VI</given-names></name><name name-style="western"><surname>Menzies</surname><given-names>FM</given-names></name><name name-style="western"><surname>Rubinsztein</surname><given-names>DC</given-names></name></person-group><article-title>Mechanisms of cross-talk between the ubiquitin-proteasome and
autophagy-lysosome systems</article-title><source>FEBS Letters</source><year>2010</year><volume>584</volume><issue>7</issue><fpage>1393</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2009.12.047</pub-id><pub-id pub-id-type="pmid">20040365</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>J</given-names></name></person-group><article-title>The proteasome: structure, function, and role in the
cell</article-title><source>Cancer Treat Rev</source><year>2003</year><volume>29</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0305-7372(03)00081-1</pub-id><pub-id pub-id-type="pmid">12738238</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciechanover</surname><given-names>A</given-names></name></person-group><article-title>Intracellular protein degradation: from a vague idea, through the
lysosome and the ubiquitin-proteasome system, and onto human diseases and
drug targeting (Nobel lecture)</article-title><source>Angew Chem Int Ed Engl</source><year>2005</year><volume>44</volume><issue>37</issue><fpage>5944</fpage><lpage>5967</lpage><pub-id pub-id-type="doi">10.1002/anie.200501428</pub-id><pub-id pub-id-type="pmid">16142822</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loureiro</surname><given-names>J</given-names></name><name name-style="western"><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Antigen presentation and the ubiquitin-proteasome system in
host-pathogen interactions</article-title><source>Adv Immunol</source><year>2006</year><volume>92</volume><fpage>225</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/S0065-2776(06)92006-9</pub-id><pub-id pub-id-type="pmid">17145306</pub-id><pub-id pub-id-type="pmcid">PMC7112114</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Traenckner</surname><given-names>EB</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>S</given-names></name><name name-style="western"><surname>Baeuerle</surname><given-names>PA</given-names></name></person-group><article-title>A proteasome inhibitor prevents activation of NF-kappa B and
stabilizes a newly phosphorylated form of I kappa B-alpha that is still
bound to NF-kappa B</article-title><source>EMBO J</source><year>1994</year><volume>13</volume><issue>22</issue><fpage>5433</fpage><lpage>5441</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1994.tb06878.x</pub-id><pub-id pub-id-type="pmid">7957109</pub-id><pub-id pub-id-type="pmcid">PMC395500</pub-id></element-citation></ref><ref id="B36"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Maniatis</surname><given-names>T</given-names></name></person-group><source>Role of the Ubiquitin-Proteasome Pathway in NF-&#954;B Activation.
InUbiquitin and the Biology of the Cell</source><publisher-loc>Boston, MA</publisher-loc><publisher-name>Springer US</publisher-name><year>1998</year><fpage>303</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1007/978-1-4899-1922-9_10</pub-id></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monsalvo-Maraver</surname><given-names>LA</given-names></name><name name-style="western"><surname>Ovalle-Noguez</surname><given-names>EA</given-names></name><name name-style="western"><surname>Nava-Osorio</surname><given-names>J</given-names></name><name name-style="western"><surname>Maya-L&#243;pez</surname><given-names>M</given-names></name><name name-style="western"><surname>Rangel-L&#243;pez</surname><given-names>E</given-names></name><name name-style="western"><surname>T&#250;nez</surname><given-names>I</given-names></name><name name-style="western"><surname>Tinkov</surname><given-names>AA</given-names></name><name name-style="western"><surname>Tizabi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Aschner</surname><given-names>M</given-names></name><name name-style="western"><surname>Santamar&#237;a</surname><given-names>A</given-names></name></person-group><article-title>Interactions Between the Ubiquitin-Proteasome System, Nrf2, and
the Cannabinoidome as Protective Strategies to Combat Neurodegeneration:
Review on Experimental Evidence</article-title><source>Neurotox Res</source><year>2024</year><volume>42</volume><issue>18</issue><pub-id pub-id-type="doi">10.1007/s12640-024-00694-3</pub-id><pub-id pub-id-type="pmcid">PMC10891226</pub-id><pub-id pub-id-type="pmid">38393521</pub-id></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name><name name-style="western"><surname>Hammoudi</surname><given-names>D</given-names></name></person-group><article-title>Use of toxic fraction isolated from Algerian Androctonus
australis hector scorpion venom for the assessment of anti-venom
serum</article-title><source>Arch Inst Pasteur Alger</source><year>1998</year><volume>62</volume><fpage>254</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">11256315</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Pathophysiological effects of Androctonus australis hector
scorpion venom: tissue damages and inflammatory response</article-title><source>Experimental and toxicologic pathology</source><year>2008</year><volume>60</volume><issue>4-5</issue><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2008.03.006</pub-id><pub-id pub-id-type="pmid">18519162</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matos</surname><given-names>IM</given-names></name><name name-style="western"><surname>Souza</surname><given-names>DG</given-names></name><name name-style="western"><surname>Seabra</surname><given-names>DG</given-names></name><name name-style="western"><surname>Freire-Maia</surname><given-names>L</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>MM</given-names></name></person-group><article-title>Effects of tachykinin NK1 or PAF receptor blockade on the lung
injury induced by scorpion venom in rats</article-title><source>Eur J Pharmacol</source><year>1999</year><volume>376</volume><issue>3</issue><fpage>293</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(99)00382-9</pub-id><pub-id pub-id-type="pmid">10448890</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coelho</surname><given-names>FM</given-names></name><name name-style="western"><surname>Pessini</surname><given-names>AC</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>AM</given-names></name><name name-style="western"><surname>Pinho</surname><given-names>VS</given-names></name><name name-style="western"><surname>Souza</surname><given-names>DG</given-names></name><name name-style="western"><surname>Arantes</surname><given-names>EC</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>MM</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>AL</given-names></name></person-group><article-title>Platelet activating factor receptors drive CXC chemokine
production, neutrophil influx and edema formation in the lungs of mice
injected with Tityus serrulatus venom</article-title><source>Toxicon</source><year>2007</year><volume>50</volume><issue>3</issue><fpage>420</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2007.04.009</pub-id><pub-id pub-id-type="pmid">17532358</pub-id></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Oosterhout</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Van Ark</surname><given-names>I</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>G</given-names></name><name name-style="western"><surname>Van Der Linde</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Fattah</surname><given-names>D</given-names></name><name name-style="western"><surname>Nijkamp</surname><given-names>FP</given-names></name></person-group><article-title>Role of interleukin-5 and substance P in development of airway
hyperreactivity to histamine in guinea-pigs</article-title><source>Eur Respir J</source><year>1996</year><volume>9</volume><issue>3</issue><fpage>493</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1183/09031936.96.09030493</pub-id><pub-id pub-id-type="pmid">8730009</pub-id></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loscalzo</surname><given-names>J</given-names></name></person-group><article-title>What we know and don&#8217;t know about L-arginine and
NO</article-title><source>Circulation</source><year>2000</year><volume>101</volume><issue>18</issue><fpage>2126</fpage><lpage>2129</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.18.2126</pub-id><pub-id pub-id-type="pmid">10801749</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pick</surname><given-names>E</given-names></name><name name-style="western"><surname>Keisari</surname><given-names>Y</given-names></name></person-group><article-title>A simple colorimetric method for the measurement of hydrogen
peroxide produced by cells in culture</article-title><source>J Immunol Methods</source><year>1980</year><volume>38</volume><issue>1-2</issue><fpage>161</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(80)90340-3</pub-id><pub-id pub-id-type="pmid">6778929</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>I</given-names></name><name name-style="western"><surname>Pichardo</surname><given-names>S</given-names></name><name name-style="western"><surname>Jos</surname><given-names>A</given-names></name><name name-style="western"><surname>Gomez-Amores</surname><given-names>L</given-names></name><name name-style="western"><surname>Mate</surname><given-names>A</given-names></name><name name-style="western"><surname>Vazquez</surname><given-names>CM</given-names></name><name name-style="western"><surname>Camean</surname><given-names>AM</given-names></name></person-group><article-title>Antioxidant enzyme activity and lipid peroxidation in liver and
kidney of rats exposed to microcystin-LR administered
intraperitoneally</article-title><source>Toxicon</source><year>2005</year><volume>45</volume><issue>4</issue><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2004.11.001</pub-id><pub-id pub-id-type="pmid">15733560</pub-id></element-citation></ref><ref id="B46"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Aebi</surname><given-names>H</given-names></name></person-group><part-title>Catalase</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Bergmeyer</surname><given-names>HU</given-names></name></person-group><source>Methods of enzymatic analysis</source><publisher-loc>Weinheim</publisher-loc><publisher-loc>NewYork</publisher-loc><publisher-name>Verlag Chemie</publisher-name><publisher-name>Academic Press Inc</publisher-name><year>1974</year><fpage>673</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-091302-2.50032-3</pub-id></element-citation></ref><ref id="B47"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Role of glutathione in the accumulation of anticarcinogenic
isothiocyanates and their glutathione conjugates by murine hepatoma
cells</article-title><source>Carcinogenesis</source><year>2000</year><volume>21</volume><issue>6</issue><fpage>1175</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1093/carcin/21.6.1175</pub-id><pub-id pub-id-type="pmid">10837007</pub-id></element-citation></ref><ref id="B48"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meki</surname><given-names>AR</given-names></name><name name-style="western"><surname>El-Dean</surname><given-names>ZM</given-names></name></person-group><article-title>Serum interleukin-1&#946;, interleukin-6, nitric oxide and
&#945;1-antitrypsin in scorpion envenomed children</article-title><source>Toxicon</source><year>1998</year><volume>36</volume><issue>12</issue><fpage>1851</fpage><lpage>1859</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(98)00106-8</pub-id><pub-id pub-id-type="pmid">9839669</pub-id></element-citation></ref><ref id="B49"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borges</surname><given-names>CM</given-names></name><name name-style="western"><surname>Silveira</surname><given-names>MR</given-names></name><name name-style="western"><surname>Aparecida</surname><given-names>M</given-names></name><name name-style="western"><surname>Beker</surname><given-names>CL</given-names></name><name name-style="western"><surname>Freire-Maia</surname><given-names>L</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>MM</given-names></name></person-group><article-title>Scorpion venom-induced neutrophilia is inhibited by a PAF
receptor antagonist in the rat</article-title><source>J Leukoc Biol</source><year>2000</year><volume>67</volume><issue>4</issue><fpage>515</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(98)00106-8</pub-id><pub-id pub-id-type="pmid">10770284</pub-id></element-citation></ref><ref id="B50"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pessini</surname><given-names>AC</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>AM</given-names></name><name name-style="western"><surname>Faccioli</surname><given-names>LH</given-names></name><name name-style="western"><surname>Greg&#243;rio</surname><given-names>ZM</given-names></name><name name-style="western"><surname>Arantes</surname><given-names>EC</given-names></name></person-group><article-title>Time course of acute-phase response induced by Tityus serrulatus
venom and TsTX-I in mice</article-title><source>Int Immunopharmacol</source><year>2003</year><volume>3</volume><issue>5</issue><fpage>765</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1016/S1567-5769(03)00078-X</pub-id><pub-id pub-id-type="pmid">12757745</pub-id></element-citation></ref><ref id="B51"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaddache</surname><given-names>A</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>M</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name></person-group><article-title>Switch of steady-state to an accelerated granulopoiesis in
response to Androctonus australis hector venom</article-title><source>Inflammation</source><year>2017</year><volume>40</volume><fpage>871</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1007/s10753-017-0532-6</pub-id><pub-id pub-id-type="pmid">28251447</pub-id></element-citation></ref><ref id="B52"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siddall</surname><given-names>EC</given-names></name><name name-style="western"><surname>Radhakrishnan</surname><given-names>J</given-names></name></person-group><article-title>The pathophysiology of edema formation in the nephrotic
syndrome</article-title><source>Kidney Int</source><year>2012</year><volume>82</volume><issue>6</issue><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1038/ki.2012.180</pub-id><pub-id pub-id-type="pmid">22718186</pub-id></element-citation></ref><ref id="B53"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuliani</surname><given-names>JP</given-names></name><name name-style="western"><surname>Freitas</surname><given-names>TA</given-names></name><name name-style="western"><surname>Concei&#231;&#227;o</surname><given-names>IM</given-names></name><name name-style="western"><surname>Kwasniewski</surname><given-names>FH</given-names></name></person-group><article-title>Tityus serrulatus venom increases vascular permeability in
selected airway tissues in a mast cell-independent way</article-title><source>Exp Toxicol Pathol</source><year>2013</year><volume>65</volume><issue>3</issue><fpage>229</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2011.08.010</pub-id><pub-id pub-id-type="pmid">21920722</pub-id></element-citation></ref><ref id="B54"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fatani</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Al-Zuhair</surname><given-names>HA</given-names></name><name name-style="western"><surname>Yaquob</surname><given-names>HI</given-names></name><name name-style="western"><surname>Abdel-Fattah</surname><given-names>AA</given-names></name><name name-style="western"><surname>El-Sayed</surname><given-names>MI</given-names></name><name name-style="western"><surname>El-Sayed</surname><given-names>FA</given-names></name></person-group><article-title>Protective effects of the antioxidant Ginkgo biloba extract and
the protease inhibitor aprotinin against Leiurus quinquestriatus
venom-induced tissue damage in rats</article-title><source>J Venom Anim Toxinsincl Trop Dis</source><year>2006</year><volume>12</volume><fpage>255</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1590/S1678-91992006000200008</pub-id></element-citation></ref><ref id="B55"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>C</given-names></name><name name-style="western"><surname>Guimaraes</surname><given-names>JT</given-names></name><name name-style="western"><surname>Barros</surname><given-names>H</given-names></name></person-group><article-title>Central obesity as a major determinant of increased
high-sensitivity C-reactive protein in metabolic syndrome</article-title><source>Int J Obes</source><year>2005</year><volume>29</volume><issue>12</issue><fpage>1452</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0803035</pub-id><pub-id pub-id-type="pmid">16077717</pub-id></element-citation></ref><ref id="B56"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tohamy</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>AF</given-names></name><name name-style="western"><surname>Moneim</surname><given-names>AEA</given-names></name><name name-style="western"><surname>Diab</surname><given-names>MS</given-names></name></person-group><article-title>Biological effects of Naja haje crude venom on the hepatic and
renal tissues of mice</article-title><source>J King Saud Univ Sci</source><year>2014</year><volume>26</volume><fpage>205</fpage><lpage>212</lpage></element-citation></ref><ref id="B57"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>SM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CH</given-names></name><name name-style="western"><surname>Shen</surname><given-names>FH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Shieh</surname><given-names>CC</given-names></name></person-group><article-title>Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B
Activation and Ameliorates Eye Inflammation in Experimental Autoimmune
Uveitis</article-title><source>Mediators Inflamm</source><year>2015</year><volume>2015</volume><issue>1</issue><elocation-id>847373</elocation-id><pub-id pub-id-type="doi">10.1155/2015/847373</pub-id><pub-id pub-id-type="pmid">25653480</pub-id><pub-id pub-id-type="pmcid">PMC4306382</pub-id></element-citation></ref><ref id="B58"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>FT</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YC</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CH</given-names></name></person-group><article-title>Anti-inflammatory effect of the proteasome inhibitor bortezomib
on endotoxin-induced uveitis in rats</article-title><source>Invest Ophthalmol Vis Sci</source><year>2012</year><volume>53</volume><issue>7</issue><fpage>3682</fpage><lpage>3694</lpage><pub-id pub-id-type="doi">10.1167/iovs.12-9505</pub-id><pub-id pub-id-type="pmid">22538426</pub-id></element-citation></ref><ref id="B59"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos</surname><given-names>F</given-names></name><name name-style="western"><surname>Abrigo</surname><given-names>J</given-names></name><name name-style="western"><surname>Aguirre</surname><given-names>F</given-names></name><name name-style="western"><surname>Garc&#233;s</surname><given-names>B</given-names></name><name name-style="western"><surname>Arrese</surname><given-names>M</given-names></name><name name-style="western"><surname>Karpen</surname><given-names>S</given-names></name><name name-style="western"><surname>Cabrera</surname><given-names>D</given-names></name><name name-style="western"><surname>And&#237;a</surname><given-names>ME</given-names></name><name name-style="western"><surname>Simon</surname><given-names>F</given-names></name><name name-style="western"><surname>Cabello-Verrugio</surname><given-names>C</given-names></name></person-group><article-title>Sarcopenia in a mice model of chronic liver disease: role of the
ubiquitin-proteasome system and oxidative stress</article-title><source>Pfl&#252;gers Archiv-Eur J Physiol</source><year>2018</year><volume>470</volume><fpage>1503</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1007/s00424-018-2167-3</pub-id><pub-id pub-id-type="pmid">29926227</pub-id></element-citation></ref><ref id="B60"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goetzke</surname><given-names>CC</given-names></name><name name-style="western"><surname>Ebstein</surname><given-names>F</given-names></name><name name-style="western"><surname>Kallinich</surname><given-names>T</given-names></name></person-group><article-title>Role of proteasomes in inflammation</article-title><source>J Clin Med</source><year>2021</year><volume>10</volume><issue>8</issue><elocation-id>1783</elocation-id><pub-id pub-id-type="doi">10.3390/jcm10081783</pub-id><pub-id pub-id-type="pmid">33923887</pub-id><pub-id pub-id-type="pmcid">PMC8072576</pub-id></element-citation></ref><ref id="B61"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruscitti</surname><given-names>P</given-names></name><name name-style="western"><surname>Currado</surname><given-names>D</given-names></name><name name-style="western"><surname>Rivellese</surname><given-names>F</given-names></name><name name-style="western"><surname>Vomero</surname><given-names>M</given-names></name><name name-style="western"><surname>Navarini</surname><given-names>L</given-names></name><name name-style="western"><surname>Cipriani</surname><given-names>P</given-names></name><name name-style="western"><surname>Pitzalis</surname><given-names>C</given-names></name><name name-style="western"><surname>Giacomelli</surname><given-names>R</given-names></name></person-group><article-title>Diminished expression of the ubiquitin-proteasome system in early
treatment-na&#239;ve patients with rheumatoid arthritis and concomitant type 2
diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC
cohort</article-title><source>Arthritis Res Ther</source><year>2024</year><volume>26</volume><issue>1</issue><elocation-id>171</elocation-id><pub-id pub-id-type="doi">10.1186/s13075-024-03392-9</pub-id><pub-id pub-id-type="pmid">39342401</pub-id><pub-id pub-id-type="pmcid">PMC11437779</pub-id></element-citation></ref><ref id="B62"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Megdad-Lamraoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Cerebrospinal inflammatory response following scorpion
envenomation: role of histamine H1 and H3 receptors</article-title><source>Inflammopharmacology</source><year>2019</year><volume>27</volume><fpage>589</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1007/s10787-018-00553-6</pub-id><pub-id pub-id-type="pmid">30604198</pub-id></element-citation></ref><ref id="B63"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sami-Merah</surname><given-names>S</given-names></name><name name-style="western"><surname>Hammoudi-Triki</surname><given-names>D</given-names></name><name name-style="western"><surname>Martin-Eauclaire</surname><given-names>MF</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Combination of two antibody fragments F (ab&#8242;) 2/Fab: An
alternative for scorpion envenoming treatment</article-title><source>Int Immunopharmacol</source><year>2008</year><volume>8</volume><issue>10</issue><fpage>1386</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2008.05.011</pub-id><pub-id pub-id-type="pmid">18687300</pub-id></element-citation></ref><ref id="B64"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cupo</surname><given-names>P</given-names></name><name name-style="western"><surname>Hering</surname><given-names>SE</given-names></name></person-group><article-title>Cardiac troponin I release after severe scorpion envenoming by
Tityus serrulatus</article-title><source>Toxicon</source><year>2002</year><volume>40</volume><issue>6</issue><fpage>823</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(02)00080-6</pub-id><pub-id pub-id-type="pmid">12175620</pub-id></element-citation></ref><ref id="B65"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soeters</surname><given-names>PB</given-names></name><name name-style="western"><surname>Wolfe</surname><given-names>RR</given-names></name><name name-style="western"><surname>Shenkin</surname><given-names>A</given-names></name></person-group><article-title>Hypoalbuminemia: pathogenesis and clinical
significance</article-title><source>J Parenter Enteral Nutr</source><year>2019</year><volume>43</volume><issue>2</issue><fpage>181</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1002/jpen.1451</pub-id><pub-id pub-id-type="pmcid">PMC7379941</pub-id><pub-id pub-id-type="pmid">30288759</pub-id></element-citation></ref><ref id="B66"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsner</surname><given-names>J</given-names></name><name name-style="western"><surname>Dichmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Kapp</surname><given-names>A</given-names></name></person-group><article-title>Activation of the respiratory burst in human eosinophils by
chemotaxins requires intracellular calcium fluxes</article-title><source>J Invest Dermatol</source><year>1995</year><volume>105</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">7636306</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1523-1747.ep12317519</pub-id></element-citation></ref><ref id="B67"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Defraigne</surname><given-names>JO</given-names></name><name name-style="western"><surname>Pincemail</surname><given-names>J</given-names></name><name name-style="western"><surname>Larbuisson</surname><given-names>R</given-names></name><name name-style="western"><surname>Blaffart</surname><given-names>F</given-names></name><name name-style="western"><surname>Limet</surname><given-names>R</given-names></name></person-group><part-title>Cytokine release and neutrophil activation are not prevented by
heparin-coated circuits and aprotinin administration</part-title><source>Ann Thorac Surg</source><year>2000</year><volume>69</volume><issue>4</issue><fpage>1084</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(00)01093-6</pub-id><pub-id pub-id-type="pmid">10800798</pub-id></element-citation></ref><ref id="B68"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>H</given-names></name><name name-style="western"><surname>Sawada</surname><given-names>T</given-names></name><name name-style="western"><surname>Oshima</surname><given-names>S</given-names></name><name name-style="western"><surname>Kozawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Ishioka</surname><given-names>T</given-names></name><name name-style="western"><surname>Kato</surname><given-names>M</given-names></name></person-group><article-title>Toxicity and roles of reactive oxygen species</article-title><source>Curr Drug Targets Inflamm Allergy</source><year>2005</year><volume>4</volume><issue>4</issue><fpage>489</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.2174/1568010054526287</pub-id><pub-id pub-id-type="pmid">16101527</pub-id></element-citation></ref><ref id="B69"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lardinois</surname><given-names>OM</given-names></name><name name-style="western"><surname>Mestdagh</surname><given-names>MM</given-names></name><name name-style="western"><surname>Rouxhet</surname><given-names>PG</given-names></name></person-group><article-title>Reversible inhibition and irreversible inactivation of catalase
in presence of hydrogen peroxide</article-title><source>Biochim Biophys Acta</source><year>1996</year><volume>1295</volume><issue>2</issue><fpage>222</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/0167-4838(96)00043</pub-id><pub-id pub-id-type="pmid">8695649</pub-id></element-citation></ref><ref id="B70"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folkerts</surname><given-names>G</given-names></name><name name-style="western"><surname>Kloek</surname><given-names>J</given-names></name><name name-style="western"><surname>Muijsers</surname><given-names>RB</given-names></name><name name-style="western"><surname>Nijkamp</surname><given-names>FP</given-names></name></person-group><article-title>Reactive nitrogen and oxygen species in airway
inflammation</article-title><source>Eur J Pharmacol</source><year>2001</year><volume>429</volume><issue>1-3</issue><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(01)01324-3</pub-id><pub-id pub-id-type="pmid">11698045</pub-id></element-citation></ref><ref id="B71"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daachi</surname><given-names>F</given-names></name><name name-style="western"><surname>Adi-Bessalem</surname><given-names>S</given-names></name><name name-style="western"><surname>Megdad-Lamraoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Influence of envenomation timing on peripheral immune and
oxidative responses in experimental scorpion envenomation</article-title><source>J Venom Anim Toxinsincl Trop Dis</source><year>2025</year><volume>31</volume><elocation-id>e20240059</elocation-id><pub-id pub-id-type="doi">10.1590/1678-9199-JVATITD-2024-0059</pub-id><pub-id pub-id-type="pmcid">PMC11960785</pub-id><pub-id pub-id-type="pmid">40170759</pub-id></element-citation></ref><ref id="B72"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Boussag-Abib</surname><given-names>L</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Safe antigens: their use in immune sera production and vaccine
approach</article-title><source>InImmunology</source><year>2011</year><volume>135</volume><fpage>204</fpage><lpage>204</lpage><comment>COMMERCE PLACE, 350 MAIN ST, MALDEN 02148</comment><publisher-loc>MA USA</publisher-loc><publisher-name>WILEY-BLACKWELL</publisher-name><pub-id pub-id-type="doi">10.1016/j.vaccine.2011.09.044</pub-id></element-citation></ref><ref id="B73"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoccal</surname><given-names>KF</given-names></name><name name-style="western"><surname>Bitencourt</surname><given-names>CD</given-names></name><name name-style="western"><surname>Paula-Silva</surname><given-names>FW</given-names></name><name name-style="western"><surname>Sorgi</surname><given-names>CA</given-names></name><name name-style="western"><surname>de Castro Figueiredo Bordon</surname><given-names>K</given-names></name><name name-style="western"><surname>Arantes</surname><given-names>EC</given-names></name><name name-style="western"><surname>Faccioli</surname><given-names>LH</given-names></name></person-group><article-title>TLR2, TLR4 and CD14 recognize venom-associated molecular patterns
from Tityus serrulatus to induce macrophage-derived inflammatory
mediators</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><elocation-id>e88174</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088174</pub-id><pub-id pub-id-type="pmid">24516606</pub-id><pub-id pub-id-type="pmcid">PMC3917877</pub-id></element-citation></ref><ref id="B74"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taibi-Djennah</surname><given-names>Z</given-names></name><name name-style="western"><surname>Laraba-Djebari</surname><given-names>F</given-names></name></person-group><article-title>Effect of cytokine antibodies in the immunomodulation of
inflammatory response and metabolic disorders induced by scorpion
venom</article-title><source>Int Immunopharmacol</source><year>2015</year><volume>27</volume><issue>1</issue><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2015.05.002</pub-id><pub-id pub-id-type="pmid">25979759</pub-id></element-citation></ref><ref id="B75"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bahloul</surname><given-names>M</given-names></name><name name-style="western"><surname>Chabchoub</surname><given-names>I</given-names></name><name name-style="western"><surname>Chaari</surname><given-names>A</given-names></name><name name-style="western"><surname>Chtara</surname><given-names>K</given-names></name><name name-style="western"><surname>Kallel</surname><given-names>H</given-names></name><name name-style="western"><surname>Dammak</surname><given-names>H</given-names></name><name name-style="western"><surname>Ksibi</surname><given-names>H</given-names></name><name name-style="western"><surname>Chelly</surname><given-names>H</given-names></name><name name-style="western"><surname>Rekik</surname><given-names>N</given-names></name><name name-style="western"><surname>Hamida</surname><given-names>CB</given-names></name><name name-style="western"><surname>Bouaziz</surname><given-names>M</given-names></name></person-group><article-title>Scorpion envenomation among children: clinical manifestations and
outcome (analysis of 685 cases)</article-title><source>Am J Trop Med Hyg</source><year>2010</year><volume>83</volume><issue>5</issue><elocation-id>1084</elocation-id><pub-id pub-id-type="doi">10.4269/ajtmh.2010.10-0036</pub-id><pub-id pub-id-type="pmid">21036842</pub-id><pub-id pub-id-type="pmcid">PMC2963974</pub-id></element-citation></ref><ref id="B76"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bahloul</surname><given-names>M</given-names></name><name name-style="western"><surname>Chaari</surname><given-names>A</given-names></name><name name-style="western"><surname>Dammak</surname><given-names>H</given-names></name><name name-style="western"><surname>Samet</surname><given-names>M</given-names></name><name name-style="western"><surname>Chtara</surname><given-names>K</given-names></name><name name-style="western"><surname>Chelly</surname><given-names>H</given-names></name><name name-style="western"><surname>Hamida</surname><given-names>CB</given-names></name><name name-style="western"><surname>Kallel</surname><given-names>H</given-names></name><name name-style="western"><surname>Bouaziz</surname><given-names>M</given-names></name></person-group><article-title>Pulmonary edema following scorpion envenomation: mechanisms,
clinical manifestations, diagnosis and treatment</article-title><source>Int J Cardiol</source><year>2013</year><volume>162</volume><issue>2</issue><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2011.10.013</pub-id><pub-id pub-id-type="pmid">22075406</pub-id></element-citation></ref><ref id="B77"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abroug</surname><given-names>F</given-names></name><name name-style="western"><surname>Souheil</surname><given-names>E</given-names></name><name name-style="western"><surname>Ouanes</surname><given-names>I</given-names></name><name name-style="western"><surname>Dachraoui</surname><given-names>F</given-names></name><name name-style="western"><surname>Fekih-Hassen</surname><given-names>M</given-names></name><name name-style="western"><surname>Ouanes Besbes</surname><given-names>L</given-names></name></person-group><article-title>Scorpion-related cardiomyopathy: clinical characteristics,
pathophysiology, and treatment</article-title><source>Clin Toxicol</source><year>2015</year><volume>53</volume><issue>6</issue><fpage>511</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.3109/15563650.2015.1030676</pub-id><pub-id pub-id-type="pmid">25851549</pub-id></element-citation></ref><ref id="B78"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valavi</surname><given-names>E</given-names></name><name name-style="western"><surname>Ansari</surname><given-names>MA</given-names></name></person-group><article-title>Hemolytic uremic syndrome following Hemiscorpius lepturus
(scorpion) sting</article-title><source>Indian J Nephrol</source><year>2008</year><volume>18</volume><issue>4</issue><fpage>166</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.4103/0971-4065.45293</pub-id><pub-id pub-id-type="pmid">20142930</pub-id><pub-id pub-id-type="pmcid">PMC2813541</pub-id></element-citation></ref><ref id="B79"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bahloul</surname><given-names>M</given-names></name><name name-style="western"><surname>Hmida</surname><given-names>B</given-names></name><name name-style="western"><surname>Belhoul</surname><given-names>W</given-names></name><name name-style="western"><surname>Ksibi</surname><given-names>H</given-names></name><name name-style="western"><surname>Kallel</surname><given-names>H</given-names></name><name name-style="western"><surname>Chaari</surname><given-names>A</given-names></name><name name-style="western"><surname>Chelly</surname><given-names>H</given-names></name><name name-style="western"><surname>Rekik</surname><given-names>N</given-names></name><name name-style="western"><surname>Bouaziz</surname><given-names>M</given-names></name></person-group><article-title>Hemolytic-uremic syndrome secondary to scorpion envenomation
(apropos of 2 cases)</article-title><source>Nephrologie</source><year>2004</year><volume>25</volume><issue>2</issue><fpage>49</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15119220</pub-id></element-citation></ref><ref id="B80"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krkic-Dautovic</surname><given-names>S</given-names></name><name name-style="western"><surname>Begovic</surname><given-names>B</given-names></name></person-group><article-title>Acute renal insufficiency and toxic hepatitis following scorpions
sting</article-title><source>Medicinski Arhiv</source><year>2007</year><volume>61</volume><issue>2</issue><fpage>123</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">17629151</pub-id></element-citation></ref><ref id="B81"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al</surname><given-names>B</given-names></name><name name-style="western"><surname>Yarbil</surname><given-names>P</given-names></name><name name-style="western"><surname>Zengin</surname><given-names>S</given-names></name><name name-style="western"><surname>Ercan</surname><given-names>S</given-names></name><name name-style="western"><surname>Davutoglu</surname><given-names>V</given-names></name><name name-style="western"><surname>Yildirim</surname><given-names>C</given-names></name></person-group><article-title>Impact of scorpion stings on electrocardiographic changes and
relationship with body oxidant and antioxidant status</article-title><source>J Pak Med Assoc</source><year>2014</year><volume>64</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">24864637</pub-id></element-citation></ref><ref id="B82"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>X</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Therapeutic potential of the proteasome inhibitor Bortezomib on
titanium particle-induced inflammation in a murine model</article-title><source>Inflammation</source><year>2012</year><volume>35</volume><fpage>905</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1007/s10753-011-9392-7</pub-id><pub-id pub-id-type="pmid">21965047</pub-id></element-citation></ref><ref id="B83"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wagner-Ballon</surname><given-names>O</given-names></name><name name-style="western"><surname>Pisani</surname><given-names>DF</given-names></name><name name-style="western"><surname>Gastinne</surname><given-names>T</given-names></name><name name-style="western"><surname>Tulliez</surname><given-names>M</given-names></name><name name-style="western"><surname>Chalign&#233;</surname><given-names>R</given-names></name><name name-style="western"><surname>Lacout</surname><given-names>C</given-names></name><name name-style="western"><surname>Aurad&#233;</surname><given-names>F</given-names></name><name name-style="western"><surname>Villeval</surname><given-names>JL</given-names></name><name name-style="western"><surname>Gonin</surname><given-names>P</given-names></name><name name-style="western"><surname>Vainchenker</surname><given-names>W</given-names></name><name name-style="western"><surname>Giraudier</surname><given-names>S</given-names></name></person-group><article-title>Proteasome inhibitor bortezomib impairs both myelofibrosis and
osteosclerosis induced by high thrombopoietin levels in mice</article-title><source>Blood</source><year>2007</year><volume>110</volume><issue>1</issue><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-10-054502</pub-id><pub-id pub-id-type="pmid">17374740</pub-id></element-citation></ref><ref id="B84"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorenz</surname><given-names>M</given-names></name><name name-style="western"><surname>Wilck</surname><given-names>N</given-names></name><name name-style="western"><surname>Meiners</surname><given-names>S</given-names></name><name name-style="western"><surname>Ludwig</surname><given-names>A</given-names></name><name name-style="western"><surname>Baumann</surname><given-names>G</given-names></name><name name-style="western"><surname>Stangl</surname><given-names>K</given-names></name><name name-style="western"><surname>Stangl</surname><given-names>V</given-names></name></person-group><article-title>Proteasome inhibition prevents experimentally-induced endothelial
dysfunction</article-title><source>Life Sci</source><year>2009</year><volume>84</volume><issue>25-26</issue><fpage>929</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">19409913</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2009.04.016</pub-id></element-citation></ref><ref id="B85"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>L</given-names></name><name name-style="western"><surname>Laevsky</surname><given-names>G</given-names></name><name name-style="western"><surname>Giardina</surname><given-names>C</given-names></name></person-group><article-title>Butyrate suppression of colonocyte NF-&#954;B activation and cellular
proteasome activity</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><issue>48</issue><fpage>44641</fpage><lpage>44646</lpage><pub-id pub-id-type="doi">10.1074/jbc.M105170200</pub-id><pub-id pub-id-type="pmid">11572859</pub-id></element-citation></ref><ref id="B86"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amit</surname><given-names>S</given-names></name><name name-style="western"><surname>Ben-Neriah</surname><given-names>Y</given-names></name></person-group><article-title>NF-&#954;B activation in cancer: a challenge for ubiquitination-and
proteasome-based therapeutic approach</article-title><source>Semin Cancer Biol</source><year>2003</year><volume>13</volume><issue>1</issue><fpage>15</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/S1044-579X(02)00096-2</pub-id><pub-id pub-id-type="pmid">12507553</pub-id></element-citation></ref><ref id="B87"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smr&#382;</surname><given-names>D</given-names></name><name name-style="western"><surname>Iwaki</surname><given-names>S</given-names></name><name name-style="western"><surname>McVicar</surname><given-names>DW</given-names></name><name name-style="western"><surname>Metcalfe</surname><given-names>DD</given-names></name><name name-style="western"><surname>Gilfillan</surname><given-names>AM</given-names></name></person-group><article-title>TLR-mediated signaling pathways circumvent the requirement for
DAP12 in mast cells for the induction of inflammatory mediator
release</article-title><source>Eur J Immunol</source><year>2010</year><volume>40</volume><issue>12</issue><fpage>3557</fpage><lpage>3569</lpage><pub-id pub-id-type="pmid">21108475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.201040573</pub-id><pub-id pub-id-type="pmcid">PMC3393881</pub-id></element-citation></ref><ref id="B88"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>E</given-names></name><name name-style="western"><surname>Carbone</surname><given-names>F</given-names></name><name name-style="western"><surname>Augusti</surname><given-names>V</given-names></name><name name-style="western"><surname>Patrone</surname><given-names>F</given-names></name><name name-style="western"><surname>Ballestrero</surname><given-names>A</given-names></name><name name-style="western"><surname>Nencioni</surname><given-names>A</given-names></name></person-group><article-title>Proteasome inhibitors as immunosuppressants: biological rationale
and clinical experience</article-title><source>Semin Hematol</source><year>2012</year><volume>49</volume><issue>3</issue><fpage>270</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1053/j.seminhematol.2012.04.004</pub-id><pub-id pub-id-type="pmid">22726551</pub-id></element-citation></ref><ref id="B89"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pellom</surname><given-names>ST</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Dudimah</surname><given-names>DF</given-names></name><name name-style="western"><surname>Thounaojam</surname><given-names>MC</given-names></name><name name-style="western"><surname>Sayers</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Shanker</surname><given-names>A</given-names></name></person-group><article-title>Modulatory effects of bortezomib on host immune cell
functions</article-title><source>Immunotherapy</source><year>2015</year><volume>7</volume><issue>9</issue><fpage>1011</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.2217/imt.15.66</pub-id><pub-id pub-id-type="pmid">26325610</pub-id><pub-id pub-id-type="pmcid">PMC4648628</pub-id></element-citation></ref><ref id="B90"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohty</surname><given-names>M</given-names></name><name name-style="western"><surname>Brissot</surname><given-names>E</given-names></name><name name-style="western"><surname>Savani</surname><given-names>BN</given-names></name><name name-style="western"><surname>Gaugler</surname><given-names>B</given-names></name></person-group><article-title>Effects of bortezomib on the immune system: a focus on immune
regulation</article-title><source>Biol Blood Marrow Transplant</source><year>2013</year><volume>19</volume><issue>10</issue><fpage>1416</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2013.05.011</pub-id><pub-id pub-id-type="pmid">23707853</pub-id></element-citation></ref><ref id="B91"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Guilpain</surname><given-names>P</given-names></name><name name-style="western"><surname>Guillevin</surname><given-names>L</given-names></name><name name-style="western"><surname>Mouthon</surname><given-names>L</given-names></name></person-group><source>Eosinophil granule cationic proteins: eosinophil activation
markers</source><year>2006</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.revmed.2006.01.008</pub-id><pub-id pub-id-type="pmid">16510214</pub-id></element-citation></ref><ref id="B92"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Astarci</surname><given-names>E</given-names></name><name name-style="western"><surname>Sade</surname><given-names>A</given-names></name><name name-style="western"><surname>Cimen</surname><given-names>I</given-names></name><name name-style="western"><surname>Sava&#351;</surname><given-names>B</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name></person-group><article-title>The NF-&#954;B target genes ICAM-1 and VCAM-1 are differentially
regulated during spontaneous differentiation of Caco-2 cells</article-title><source>FEBS J</source><year>2012</year><volume>279</volume><issue>16</issue><fpage>2966</fpage><lpage>2986</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08677.x</pub-id><pub-id pub-id-type="pmid">22742445</pub-id></element-citation></ref><ref id="B93"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>YF</given-names></name><name name-style="western"><surname>Liu</surname><given-names>LP</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>CP</given-names></name><name name-style="western"><surname>Geng</surname><given-names>JG</given-names></name></person-group><article-title>NF-&#954;B activation for constitutive expression of VCAM-1 and ICAM-1
on B lymphocytes and plasma cells</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>289</volume><issue>4</issue><fpage>851</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.6067</pub-id><pub-id pub-id-type="pmid">11735124</pub-id></element-citation></ref><ref id="B94"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mocanu</surname><given-names>CA</given-names></name><name name-style="western"><surname>Fuior</surname><given-names>EV</given-names></name><name name-style="western"><surname>Voicu</surname><given-names>G</given-names></name><name name-style="western"><surname>Rebleanu</surname><given-names>D</given-names></name><name name-style="western"><surname>Safciuc</surname><given-names>F</given-names></name><name name-style="western"><surname>Deleanu</surname><given-names>M</given-names></name><name name-style="western"><surname>Fenyo</surname><given-names>IM</given-names></name><name name-style="western"><surname>Escriou</surname><given-names>V</given-names></name><name name-style="western"><surname>Manduteanu</surname><given-names>I</given-names></name><name name-style="western"><surname>Simionescu</surname><given-names>M</given-names></name><name name-style="western"><surname>Calin</surname><given-names>M</given-names></name></person-group><article-title>P-selectin targeted RAGE-shRNA lipoplexes alleviate
atherosclerosis-associated inflammation</article-title><source>J Control Release</source><year>2021</year><volume>338</volume><fpage>754</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2021.09.012</pub-id><pub-id pub-id-type="pmid">34530051</pub-id></element-citation></ref><ref id="B95"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gloire</surname><given-names>G</given-names></name><name name-style="western"><surname>Legrand-Poels</surname><given-names>S</given-names></name><name name-style="western"><surname>Piette</surname><given-names>J</given-names></name></person-group><article-title>NF-&#954;B activation by reactive oxygen species: fifteen years
later</article-title><source>Biochem Pharmacol</source><year>2006</year><volume>72</volume><issue>11</issue><fpage>1493</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2006.04.011</pub-id><pub-id pub-id-type="pmid">16723122</pub-id></element-citation></ref><ref id="B96"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>M</given-names></name><name name-style="western"><surname>Hyun</surname><given-names>DH</given-names></name><name name-style="western"><surname>Jenner</surname><given-names>P</given-names></name><name name-style="western"><surname>Halliwell</surname><given-names>B</given-names></name></person-group><article-title>Effect of proteasome inhibition on cellular oxidative damage,
antioxidant defences and nitric oxide production</article-title><source>J Neurochem</source><year>2001</year><volume>78</volume><issue>1</issue><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00416.x</pub-id><pub-id pub-id-type="pmid">11432971</pub-id></element-citation></ref><ref id="B97"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griscavage</surname><given-names>JM</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>S</given-names></name><name name-style="western"><surname>Ignarro</surname><given-names>LJ</given-names></name></person-group><article-title>Inhibitors of the proteasome pathway interfere with induction of
nitric oxide synthase in macrophages by blocking activation of transcription
factor NF-kappa B</article-title><source>Proc Nat Acad Sci</source><year>1996</year><volume>93</volume><issue>8</issue><fpage>3308</fpage><lpage>3312</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.8.3308</pub-id><pub-id pub-id-type="pmid">8622934</pub-id><pub-id pub-id-type="pmcid">PMC39603</pub-id></element-citation></ref><ref id="B98"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conner</surname><given-names>EM</given-names></name><name name-style="western"><surname>Brand</surname><given-names>S</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Laroux</surname><given-names>FS</given-names></name><name name-style="western"><surname>Palombella</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Fuseler</surname><given-names>JW</given-names></name><name name-style="western"><surname>Kang</surname><given-names>DY</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>RE</given-names></name><name name-style="western"><surname>Grisham</surname><given-names>MB</given-names></name></person-group><article-title>Proteasome inhibition attenuates nitric oxide synthase
expression, VCAM-1 transcription and the development of chronic
colitis</article-title><source>J Pharmacol Exp Ther</source><year>1997</year><volume>282</volume><issue>3</issue><fpage>1615</fpage><lpage>1622</lpage><pub-id pub-id-type="pmid">9316879</pub-id></element-citation></ref><ref id="B99"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>LH</given-names></name><name name-style="western"><surname>Fan</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Guan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Qu</surname><given-names>B</given-names></name><name name-style="western"><surname>Pei</surname><given-names>FH</given-names></name><name name-style="western"><surname>Liu</surname><given-names>BR</given-names></name></person-group><article-title>Bortezomib protects against dextran sulfate sodium-induced
ulcerative colitis in mice</article-title><source>Mol Med Rep</source><year>2017</year><volume>15</volume><issue>6</issue><fpage>4093</fpage><lpage>4099</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.6524</pub-id><pub-id pub-id-type="pmid">28487944</pub-id><pub-id pub-id-type="pmcid">PMC5436237</pub-id></element-citation></ref><ref id="B100"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexandrova</surname><given-names>A</given-names></name><name name-style="western"><surname>Petrov</surname><given-names>L</given-names></name><name name-style="western"><surname>Georgieva</surname><given-names>A</given-names></name><name name-style="western"><surname>Kirkova</surname><given-names>M</given-names></name><name name-style="western"><surname>Kukan</surname><given-names>M</given-names></name></person-group><article-title>Effects of proteasome inhibitor, MG132, on proteasome activity
and oxidative status of rat liver</article-title><source>Cell Biochem Funct</source><year>2008</year><volume>26</volume><issue>3</issue><fpage>392</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1111/j.1872-034X.2007.00270.x</pub-id><pub-id pub-id-type="pmid">18236383</pub-id></element-citation></ref><ref id="B101"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>T</given-names></name><name name-style="western"><surname>Grune</surname><given-names>T</given-names></name></person-group><article-title>The proteasome and its role in the degradation of oxidized
proteins</article-title><source>IUBMB Life</source><year>2008</year><volume>60</volume><issue>11</issue><fpage>743</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1002/iub.114</pub-id><pub-id pub-id-type="pmid">18636510</pub-id></element-citation></ref><ref id="B102"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandel</surname><given-names>R</given-names></name><name name-style="western"><surname>Jung</surname><given-names>J</given-names></name><name name-style="western"><surname>Neal</surname><given-names>S</given-names></name></person-group><article-title>Proteotoxic stress and the ubiquitin proteasome
system</article-title><source>Semin Cell Dev Biol</source><year>2024</year><volume>156</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2023.08.002</pub-id><pub-id pub-id-type="pmid">37734998</pub-id><pub-id pub-id-type="pmcid">PMC10807858</pub-id></element-citation></ref></ref-list><sec sec-type="data-availability"><title>Availability of data and materials</title><p> The datasets used and/or analyzed during the current study are available from the
corresponding author on reasonable request.</p></sec></back></article></pmc-articleset>